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PHYSIOLOGICAL RESPONSES TO FEEDING A YEAST CULTURE SUPPLEMENT 
TO TRANSITION DAIRY COWS 
NATHALY ANA CARPINELLI 
2020 
The transition period is the dynamic stage in the lactation cycle, where the most 
metabolic changes can occur. The use of nutritional strategies, such as yeast culture, can 
help cows during the transition from pregnancy to early lactation, improving health and 
decreasing the incidence of metabolic disorders.  The first objective of this research was 
to evaluate the effects of a commercial yeast culture product (YC; Cellerate Culture Classic 
HD, Phibro Animal Health, Teaneck, NJ) on performance, blood biomarkers, and rumen 
fermentation and bacterial population in dairy cows during the transition period through 50 
days in milk (DIM). Overall, the results showed that yeast culture products could promote 
positive responses on performance, such as milk yield, somatic cell count (SCC), and 
energy corrected milk (ECM). In the rumen, yeast culture product contributed to 
increased valerate, which was accompanied by improvements in rumen bacteria 
populations such as cellulolytic and lactic acid-utilizing bacteria. In addition, the results 
suggest that yeast may influence lipid metabolism in transition dairy cows, based on 
nonesterified fatty acid (NEFA) and beta-hydroxybutyrate (BHB) markers.  The second 
objective was to assess the effects of yeast-based products on metabolism, inflammation, 
liver function, and immune function through blood biomarkers and gene expression in 
polymorphonuclear leukocytes (PMNL) in dairy cows during the transition period until 
50 DIM. Yeast supplementation might stimulate a mild inflammatory response in 
xiii 
 
transition dairy cows, based on blood biomarker and PMNL mRNA expression.  In 
summary, we observed that yeast culture could promote improvements in performance, 
rumen bacteria population, and stimulate the immune system in transition dairy cows 





The transition period is associated with the peak incidence of production 
problems, metabolic disorders, and infectious diseases in dairy cows (Drackley, 1999). 
During late pregnancy and particularly in early lactation, cows enter a condition called 
negative energy balance (NEB) due to the increase in energy requirements. The NEB is 
associated with a large mobilization of fatty acids stored in adipose tissue, thus, causing 
marked elevations in blood concentrations of non-esterified fatty acids (NEFA) and β-
hydroxybutyrate (BHBA) (Drackley et al., 2006). Prolonged periods with high blood 
NEFA and BHB concentrations in the bloodstream will eventually cause further 
complications, such as metabolic disorders. In addition, during the transition period, the 
cow’s immune system is suppressed. This is linked with the metabolic challenge 
associated with the onset of lactation, which can affect the immune function.  
The advancements in dairy cow nutrition enable the development of nutritional 
strategies to help cows during the transition from pregnancy to early lactation. The 
positive effects of yeast-based products from Saccharomyces cerevisiae in transition 
dairy cows have been demonstrated (Dann et al., 2000; Yuan et al., 2015b; Olagaray et 
al., 2019). The response to yeast supplementation has been reported to improve the 
growth and activities of ruminal microbial communities and, consequently, promoting 
positive effects on milk or meat production (Fonty and Chaucheyras-Durand, 2006).  
Our general hypothesis is that yeast culture supplementation during the transition 
period through 50 DIM will alleviate metabolic challenges associated with the onset of 
lactation, and consequently improve health and performance in transition dairy cows. The 
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objective of this study was to determine the effects a commercial yeast culture product 
(YC; Cellerate Culture Classic HD, Phibro Animal Health, Teaneck, NJ) on health and 
performance and correlate these with metabolism and immune function during the 
























CHAPTER 1. LITERATURE REVIEW 
Transition period 
Dairy cows have been genetically selected for the purpose of producing more 
milk during their reproductive life. Because of this genetic selection, cows require 
adequate management and nutrition during their reproductive life in order to sustain such 
enhanced milk yield. In dairy cows, the transition period spans from 3 weeks before 
through 3 weeks after parturition (Drackley, 1999), and it is the most critical period 
during the cow’s life. It is characterized by dramatic changes in metabolism and 
physiology, where most infectious diseases and metabolic disorders can occur (Grummer, 
1995; Drackley, 1999). According to Trevisi and Minuti (2018), five critical points are 
associated with the transition period: negative energy balance (NEB) due to the increase 
in energy requirements and decrease in feed intake, which leads to mobilization of 
adipose tissue;  reduction of immune competence; systemic inflammatory condition; 
oxidative stress; and hypocalcemia.  
Physiology and metabolism  
Negative energy balance 
During late pregnancy and particularly in early lactation, the energy demands 
increased in cows due to fetal development and milk production. At the same time, cows’ 
energy intake cannot meet those energy demands. A decline in energy intake is 
commonly observed around parturition (Ingvartsen and Andersen, 2000). After 
parturition, dry matter intake (DMI) tends to increase if the cow is healthy. However, the 
health status will vary from cow to cow, which will be reflected in DMI. At the same 
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time, major changes in metabolism are commonly reported in cows in order to cope with 
the increase in nutrient requirements (Ingvartsen and Andersen, 2000). 
Postpartum NEB is universal in mammals, and it is associated with an imbalance 
between decreased energy intake and increased energy requirements for milk synthesis. 
During this condition, cows mobilize large amounts of NEFA from adipose tissue to cope 
with the energy deficit to sustain milk production (Ingvartsen and Moyes, 2013). Lipid 
mobilization occurs when adipose tissue becomes predominantly lipolytic (Contreras and 
Sordillo, 2011). This is a normal physiological adaptation due to the reduced energy 
intake, coupled with an increase in energy demands after calving (Contreras and Sordillo, 
2011).   
Canonical metabolism 
In early lactation, changes in endocrine signals and tissue metabolism have been 
observed (Ingvartsen, 2006). The changes in tissue metabolism during the transition 
period comprise liver, adipose tissue, and mammary gland. In adipose tissue, a lipolytic 
state is predominant due to low insulin during NEB, while the liver needs to maintain 
gluconeogenesis (Ingvartsen (2006). A summary of the metabolic adaptations across 
adipose tissue, liver, and mammary gland during the peripartum is presented in Figure 
1.1. During NEB, an increase in blood NEFA mobilization from adipose tissue is 
commonly observed, which may exceed the capacity of the mammary gland to pack these 
excess NEFA into milk (Drackley, 1999). The liver is the most important site to remove 
and metabolize NEFA from circulation (Van den Top et al., 2005). During an extreme 
rate of lipid mobilization, it will lead to increased uptake of NEFA by the liver (Drackley, 
1999). Once taken up by the liver, NEFA can be 1) complete oxidized through the 
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tricarboxylic acid cycle (TCA), providing energy for the liver; 2) partially oxidized to 
ketone bodies, that will serve as an energy source for tissues; 3) TG synthesis for storage 
in the liver; 4) TG synthesis to be exported into the bloodstream as a very-low density 
lipoprotein (VLDL); 5) secreted in bile (Emery et al., 1992; Ingvartsen, 2006; White, 
2015). Prolonged periods with high blood NEFA concentrations in the bloodstream will 
eventually impair the liver’s ability to oxidize NEFA, causing further complications, such 
as impaired liver function and fatty liver.    
NEFA metabolism 
Once in the liver, NEFA is converted to fatty acyl-CoA by the enzyme long-
chain-fatty-acid- acyl CoA synthetase. Fatty acyl-CoA is transported into the 
mitochondria by the coordinated effort of carnitine palmitoyltransferase I (CPT-I) and II 
(CPT-II) enzymes (Champe et al., 2005). Once inside the mitochondria, fatty acids (FA) 
undergo β-oxidation (Ingvartsen, 2006). The enzyme CPT-I is located in the outer 
mitochondrial membrane that converts fatty acyl-CoA in acylcarnitine that can be 
transported over the internal mitochondrial membrane. Then, the acylcarnitine is 
transported into the mitochondria by CPT-II, which converts acylcarnitine into fatty acyl-
CoA that is oxidized via β-oxidation. The product of β-oxidation of fatty acyl-CoA is 
Acetyl-CoA and can be further oxidized in the TCA cycle (Champe et al., 2005). In some 
instances, the TCA cycle cannot oxidize the Acetyl-CoA generated via β-oxidation 
product of low availability of TCA cycle intermediates such as oxaloacetate. In that case, 
acetyl-CoA is then used to synthesize ketone bodies (Drackley, 1999). Ketone bodies 
comprise acetoacetate (ACAC), BHB, and acetone (nonmetabolized product). The ACAC 
and BHB are transported to peripheral tissues and can be used as an energy source. 
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Excessive circulation of blood ketone bodies may negatively affect animal health and 
performance, causing metabolic disorders such as ketosis (White, 2015).   
In addition to mitochondrial β-oxidation of FAs, peroxisomal β-oxidation plays an 
alternative role in FA oxidation when these are in excess in the liver (Ingvartsen, 2006). 
The pathway is very similar to mitochondrial β-oxidation, except for the first step. The 
initial oxidation is mediated by acyl-CoA oxidase, producing hydrogen peroxidase 
(H2O2) instead of reduced NAD (Drackley, 1999). Although the peroxisome lacks of 
respiration chain and the ability to produce ATP, its activity has been related to oxidative 
stress and inflammation because of the production of H2O2, which is one of a family of 
reactive oxygen species (ROS)(Champe et al., 2005). The peroxisomal β-oxidation of FA 
is a significant source of ROS in transition dairy cows, however, most ROS found in 
healthy tissues are a product of an increase in cellular metabolism and energy generation 
by mitochondria (Drackley, 1999; Sordillo, 2016).  
Fatty acids that are not oxidized are re-esterified with glycerol to form TG. A 
portion of these TG is packaged into VLDL and exported into the bloodstream to be used 
by extra-hepatic tissues (Champe et al., 2005). The mammary gland can use the FA 
contained in VLDL for milk fat synthesis; however, these need to be uptaken with the 
help of lipoprotein lipase, a VLDL receptor that hydrolyzes TG (Osorio et al., 2016). In 
ruminants, it is well known that VLDL secretion is very limited (Grummer, 2008). The 
low rate of synthesis and secretion of VLDL in ruminants is insufficient to remove 
considerable amounts of accumulated TG in hepatocytes (Drackley et al., 2006). In 
transition dairy cows, the low secretion of VLDL from liver could be explained by the 
hepatic downregulation of mRNA expression of Apo-B100 (APOB, gene symbol), 
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contributing to the accumulation of TG in liver (Bernabucci et al., 2004; Bernabucci et 
al., 2009). Together, the oxidation of FAs, TG accumulation, and the low synthesis of 
VLDL in the liver play a central role in the development of fatty liver syndrome 
(Ingvartsen, 2006). The fatty liver syndrome implicates a limited capacity to secrete TG 
within VLDL, coupled with an increased rate of FA esterification (McFadden, 2020). 
According to Overton and Waldron (2004), almost all high-producing dairy cows 
accumulate TG in liver during the first few weeks postpartum. Grummer (1993) observed 
that fatty liver syndrome and ketosis are common metabolic disorders related to lipid 
metabolism during the transition period.  
Metabolic disorders  
Fatty liver syndrome 
The fatty liver syndrome is one of the major metabolic disorders that occur in the 
peripartal dairy cow, compromising the cow’s metabolism (Bobe et al., 2004). White 
(2015) described that during the transition between pregnancy and lactation, around 60% 
of dairy cows develop fatty liver syndrome, which is a direct response to NEB. The rapid 
decrease in prepartum DMI has been linked with greater postpartal lipid mobilization of 
adipose tissue, increased NEFA, and accumulation of TG in liver (Drackley, 1999; 
Grummer et al., 2004). 
The fatty liver syndrome commonly occurs in the early postpartum period, when 
an excess of TG  accumulate in the liver. In dairy cows developing fatty liver syndrome, 
the hepatic TG deposition is due to increased esterification of lipolytic-derived FA, and 
the process is exacerbated by inadequate mitochondrial β-oxidation of FA (McFadden, 
2020) or low production of VLDL to transport TG. The lipid accumulation causes 
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significant alterations in the liver, affecting the normal hepatic function, cow’s health, 
milk production, and reproductive performance (Bobe et al., 2004; White, 2015).  
According to Grummer (2008), there are strategies that can be used to prevent or 
treat fatty liver syndrome including: 1) decrease TG lipolysis in adipose tissue and, as a 
consequence, reduced blood NEFA; 2) increase complete hepatic oxidation of NEFA; 3) 
increase the rate of VLDL export from the liver. In this context, nutritional strategies 
have been used to prevent fatty liver syndrome, such as adjustments on prepartal plane of 
nutrition (Grum et al., 1996; Janovick et al., 2011; Osorio et al., 2013b), restricted diets 
(Van den Top et al., 2005) and nutritional supplements (i.e., rumen-protected choline and 
propylene glycol) (Grummer, 2008).  
Ketosis 
Ketosis is marked by an elevated circulation of ketone bodies associated with 
increased NEFA infiltration in the liver. Peripheral tissues can be use ketone bodies as an 
energy source; however, if the rate of ketones uptake by peripheral tissues is lower than 
the hepatic ketone production, an increase in ketone bodies will be observed, also known 
as hyperketonemia (Ingvartsen, 2006). Ketosis can be classified as a sub-clinical (SCK) 
or clinical (≥1.4 mmol/L) based on blood BHB concentrations.  
According to Oetzel (2004), cows with a clinical ketosis condition had higher 
blood BHB concentrations (>3.0 mmol/L) than the BHB threshold used to determine 
SCK. During SCK, it is observed an increase in blood, urine, or milk ketone bodies 
without clinical symptoms; and in the clinical conditions, cows presented an increase in 
blood, urine, or milk ketone bodies associated with clinical signs, such as inappetence, 
weight loss, and dry manure (Gordon et al., 2013). The incidence of SCK varies widely 
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across herds, but it has been reported to be around 60%, while clinical ketosis occurs 
between 2% to 15% (Duffield, 2000). Ketosis or fatty liver syndrome conditions have 
been negatively associated with immune function (Overton and Waldron, 2004). In a 
review paper, Bobe et al. (2004) suggested that fatty liver syndrome is indirectly 
associated with immune function because metabolic and hormonal changes attributed to 
this syndrome may interfere with immune function. Ketosis is a metabolic condition that 
can alter immune function in transition dairy cows (Zhu et al., 2019), regulate genes 
involved in lipid metabolism (Mezzetti et al., 2019), impair liver function, and lead to 
oxidative stress conditions (Rodriguez-Jimenez et al., 2018).  
Immune system 
The immune system comprises lymphoid organs, cells, and humoral factors that 
work in a communicative network to recognize, resist, and eliminate pathogens (Bertoni 
et al., 2015). The immune system is divided into innate and adaptive components, but 
these two are integrated (Daha, 2011). The innate immunity is described by an early and 
rapid response that can occur in seconds to combat a wide variety of potentially 
infectious pathogens (Sordillo, 2016). In contrast, the adaptative immune system adapts 
the response specifically to each infectious agent encountered and is delayed compared to 
the innate immune system (Sordillo, 2016).  
Innate immune system 
The innate immune system is rapidly activated during the early stages of 
infection. The major components of innate immunity include physical barriers, pattern 
recognition receptors, complement activation, cytokines, oxylipids, endothelial cells, and 
immune cells (Sordillo, 2016). The immune cells in the innate immune system are 
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leukocytes [i.e., polymorphonuclear neutrophils (PMNL), monocytes, macrophages, 
lymphocytes, eosinophils, basophils], dendritic cells, and natural killer cells. These cells 
play an important role against pathogens as well as providing communication between 
innate and adaptive immune systems.  
The pattern recognition receptors (PRR) on the surface of the immune cells are 
responsible for recognizing specific molecules on the surface of pathogens. These 
receptors detect microbial factors associated with infectious pathogens and stimulate the 
innate immune response (Sordillo, 2016). The PRR recognize two classes of 
molecules: pathogen-associated molecular patterns (PAMPs) associated with pathogen 
products; and damage-associated molecular patterns (DAMPs), which are related to host 
cell components released during cell damage or death. This recognition by PRR stimulate 
a number of responses, including cellular activity such as phagocytosis and initiation of 
the inflammatory response (Trevisi and Minuti, 2018). For instance, toll-like receptors 
(TLRs) recognize various PAMPs, which can initiate a signal pathway that induces gene 
transcription and activation of inflammatory mediators, such as cytokines and 
chemokines (Lee and Hwang, 2006). These mediators can affect endocrinal signals, 
which coordinates an inflammatory response (Ballou, 2011). 
During the early stages of the immune response, the goal is to localize and 
eliminate the infection by recruiting immune cells, mainly neutrophils, to the site of 
infection. The innate immune system combats 95% of infections through combined 
mechanisms, including the action of different cell types (e.g., PMNL, monocytes, 





Granulocytes are a subcategory of leukocytes, including PMNL, eosinophils, and 
basophils, with different cytoplasmic characteristics and cellular morphologies. The 
PMNL are the major circulating leukocytes (50-70%) and present cytoplasmatic granules 
and multilobed nucleus that can be highly differentiated from the other leukocytes (Paape 
et al., 2003). The PMNL cells are originated from myeloid lineage progenitor cells, 
synthesized, and maturated in the bone marrow. The synthesis and maturation take 
around 7 to 10 days until neutrophils release into the blood circulation (LeBlanc, 2020). 
The PMNL circulate for a short time (6 to 8 h half-life in humans; 8.9 h in cows), but the 
lifespan is extended once activated, although still to less than ∼1 day (Paape et al., 2003; 
LeBlanc, 2020). A recent study in humans suggests that neutrophils may traffick through 
more complex cycles and sites, and perhaps longer lifespans (Hidalgo et al., 2019). In 
response to an infection, PMNL are considered the first line of defense from the innate 
immune system against pathogens, mainly bacteria and virus. The inflammatory process 
initiates with PMNL migrating to the site of infection. After migration, PMNL interact 
with damaged cells or bacteria through a variety of mechanisms, including phagocytosis, 
intracellular digestion by oxidation (e.g., oxidative burst in lysosomes), and extracellular 
release of oxidants from neutrophil granules (e.g., myeloperoxidase) (LeBlanc, 2020). 
Additionally, PMNL may undergo programmed apoptosis, culminating with casting 
neutrophil extracellular traps (NETs) of DNA (LeBlanc, 2020).  
The receptors in PMNL are classified according to their function, including 
chemotactic, adhesion, cluster of differentiation (CD14), and opsonin receptors (Paape et 
al., 2003). Chemotactic receptors are activated to recognize chemoattractants that recruit 
PMNL to the site of infection. Examples of chemoattractants include chemokine (C-X-C 
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motif) ligand 8 (CXCL8) (also called IL-8), platelet-activating factor, complement 
component C5a, tumor necrosis factor α (TNFα), and PRR (Bassel and Caswell, 2018). 
Adhesion receptors provide the attachment of PMNL to the endothelium and play an 
important role in allowing PMNL to move across the endothelium adjacent to inflamed 
tissue (Paape et al., 2003). L-selectin is one example of an adhesion receptor that 
mediating the rolling of PMNL over the inflamed endothelium and subsequently 
adherence (Raffler et al., 2005). The CD14 receptors bind bacterial toxins, such as 
lipopolysaccharide (LPS) and cytokines that promote gene regulation related to the host 
defense (Paape et al., 2003). Opsonin receptors are characterized by immunoglobulins 
(e.g., IgM and IgG2) and complement components that promote bacteria recognition and 
allow PMNL to initiate phagocytosis (Paape et al., 2003). 
Pathogen recognition by neutrophils leads to phagocytosis, a process that involves 
engulfing and killing pathogens. During the respiratory burst in PMNL, large volumes of 
ROS (O2 and H2O2) are produced by stimulation of NADPH oxidase to destroy invading 
pathogens (Sordillo et al., 2009). The accumulation of ROS can damage the host’s cells 
and tissues and lead to oxidative stress in transition dairy cows. During the transition 
period, the oxidative stress may be a major underlying cause of inflammatory and 
immune dysfunction in dairy cattle, associated with parturition and a loss in antioxidant 
potential (Sordillo and Aitken, 2009). In periparturient dairy cows, different variables can 
affect neutrophil functional capacity. The main factors that influence neutrophil function 
are fat mobilization (BHB, NEFA, oxidative stress), nutrient supply (antioxidant, 
glucose, calcium),  social stressors, and exogenous immune modulators (LeBlanc, 2020). 
In addition, mRNA expression has been correlated with neutrophil function (Moyes et al., 
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2014; Batistel et al., 2017; Vailati-Riboni et al., 2019). Metabolic status alters the 
expression of genes associated with inflammation in bovine blood PMNL (Moyes et al., 
2010).   
Macrophages  
Premonocytes are synthesized in the bone marrow and released into the 
bloodstream, where they differentiate in monocytes (MO) and have a half-life of 1-2 d 
(Ziegler-Heitbrock, 2014). Once in the bloodstream, they can migrate into the tissues and 
differentiate into tissue-specific macrophages, such as intestinal macrophages (gut), 
osteoclasts (bone), kupffer cells (liver), and adipose tissue macrophages (adipose tissue). 
Macrophages form a line of defense in tissues, like a barrier against infection. Important 
functions of macrophages and monocytes include phagocytosis, ROS production, and 
secretion of pro-inflammatory cytokines during an inflammatory response (Calder, 1995). 
Macrophages are involved in the innate and adaptative immune responses because they 
can also behave as antigen-presenting cells, recruiting other immune cells to the site of 
infection through antigen presentation to T cells (Calder, 1995).  
In transition dairy cows, adipose tissue macrophages (ATM) are a key component 
during lipolysis in adipose tissue due to NEB. During lipolysis, the role of ATM is to 
remove lipolytic products (e.g., FA, diglycerides, and monoglycerides), recruitment of 
new adipocyte progenitors by secreting chemotactic proteins, and activation of NF-κB 





Lymphocytes are produced in the bone marrow and newly release lymphocytes 
are termed naïve, virgin, or unprimed. They become activated due to local antigenic 
stimulation responses and are termed memory or effector cells (Sordillo and Streicher, 
2002). Lymphocytes consist of T cells (helper or cytotoxic) and B cells (secrete 
antibody). The T cells can be subdivided into T-helper and T-cytotoxic (CTL) 
lymphocytes. The T-helper cells produce cytokines, such as interleukin-2 (IL-2) and 
interferons (IFN), crucial for an effective cell-mediated immune response. The B 
lymphocytes differentiate to produce proteins called antibodies or immunoglobulins (Ig) 
and effector B cells or plasma cells (Sordillo et al., 1997). Plasma cells are central to 
specific immunity, which have a short half-life and produce and secrete antibodies. 
The innate immune system in transition dairy cows 
Peripartal dairy cows are often regarded as immunocompromised animals because 
functions related to the immune system seem to be depressed. In a recent review paper, 
Trevisi and Minuti (2018) reported that peripartal cows have a high probability of 
experiencing events that challenge their immune system and expose any 
immunocompetence. Such effects are related to the NEB characterized by critical 
reduction of feed intake around parturition, severe body fat mobilization, production of 
ROS, and incidence of metabolic disorders.  
Before calving, the immune dysfunctions can be due to a combination of 
metabolic and endocrine factors. However, it is not clear if the reduction in 
immunocompetence is a physiological condition of transition dairy cows or an early 
signal of disease induced by other events (Trevisi and Minuti, 2018). It is well established 
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that some cellular processes essential in the immune system are depressed around 
calving, including phagocytosis by neutrophils, antibody synthesis by lymphocytes, and 
immunoglobulins concentration in plasma (Goff and Horst, 1997; Lacetera et al., 2005; 
Trevisi and Minuti, 2018). After parturition, the development of health disorders, such as 
mastitis, ketosis, retained placenta, metritis, and displaced abomasum, can contribute to 
immune dysfunction (Sordillo, 2016). In addition, metabolic changes related to energy 
and calcium supply in support of lactation can also impair the innate immune system 
(Ingvartsen and Moyes, 2013).  
Immune dysfunction has been correlated with specific factors associated with the 
transition period. For example, after calving, blood glucose is prioritized to the non-
insulin-dependent glucose transporters, which are only expressed on immune cells and 
the mammary gland. This is particularly important during systemic inflammation when 
activated immune cells have higher glucose requirements to sustain phagocytic and 
killing capacity (i.e., oxidative burst) activities (Kvidera et al., 2017). Changes in steroid 
hormones can contribute to an immune dysfunction during the transition period, mainly 
by altering the function of neutrophils (Sordillo and Mavangira, 2014). Glucocorticoids 
are known to have a potent immunosuppressive effect on blood neutrophil, while 
prepartal estradiol and progesterone were reported to affect the functional capabilities of 
immune cells (Sordillo and Mavangira, 2014). 
Inflammatory response during the transition period  
The inflammatory response comprises localized and systemic responses that 
involve physiological and pathological alterations that help the body adapt or eliminate 
adverse stimulus to return tissues to normal function or homeostasis (Bradford et al., 
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2015; Sordillo, 2016). The most common event to occur during the inflammatory 
responses is a systemic or acute phase response (APR). The mechanisms include fever, 
pain, leukocytosis, and the over- or under-expression of a large family of structurally 
unrelated proteins, the acute phase proteins (APP) (Ceciliani et al., 2012).  
The liver plays an important role during APR, coordinating the synthesis of key 
metabolites to face an inflammatory condition. The primary stimulators of the APR are 
the pro-inflammatory cytokines, including TNFα, IL1β, and IL6 (Gauldie et al., 1987). 
These cytokines can activate leukocytes and endothelial cells (Bannerman et al., 2009) 
and alter the normal synthesis of proteins in hepatocytes.  These proteins for which their 
hepatic synthesis is affected during APR are called acute phase proteins (APP). The APP 
play major roles during APR, and they are classified as positive (increase) or negative 
(decrease) APP depending on their change in blood concentration over the course of an 
inflammatory condition (Ceciliani et al., 2012). The blood concentration of positive APP 
increases during inflammation, and haptoglobin, serum amyloid A, LPS binding protein, 
ceruloplasmin, and fibrinogen are common examples of positive APP. Oppositely, 
negative APP includes paraoxonase, albumin, lipoprotein, and retinol binding protein.  
As mentioned previously, the peripartal dairy cow is an immunocompromised animal 
characterized by inflammatory conditions such as infectious diseases and metabolic 
disorders that often result in pro-inflammatory cytokine release, e.g., TNFα, IL1β, and 
IL6 (Bertoni et al., 2008). In turn, any significant increment in the severity or length of 
exposure time to these pro-inflammatory cytokines will likely induce a change in the 
hepatic activity related to the synthesis of APP.  
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Nutritional strategies during the transition period  
In past years, valuable information about the condition of cows undergoing the 
transition from pregnancy to early lactation has been reviewed, including nutritional and 
management approaches to minimize the incidence of postpartal metabolic and 
reproductive related diseases (Drackley, 1999; Ingvartsen, 2006; Sordillo, 2016). 
Prepartal DMI has a major effect on postpartal DMI and peripartal lipid metabolism, 
which, in turn, influence the incidence of health disorders (Drackley, 1999).  Ingvartsen 
(2006) reported a link between body fatness at calving and subsequent degree of lipid 
mobilization, underscoring the importance of managing dairy cows to calve at the 
optimum body fatness to decrease the risk of developing health disorders. Later, Sordillo 
(2016) focused more on the connection between nutritional strategies and the immune 
system, suggesting that the development of nutritional-based strategies that can enhance 
the immune response will have a prominent role in food animal agriculture. 
Dairy cattle research has demonstrated the potential of nutritional strategies such 
as manipulation of prepartal energy intake (Grum et al., 1996; Janovick et al., 2011; Zhou 
et al., 2015), supplementation with amino acids (Osorio et al., 2013a; Zhou et al., 2016; 
Abdelmegeid et al., 2018), and yeast-based products (Zaworski et al., 2014; Yuan et al., 
2015b; Stefenoni et al., 2020) to improve the health as well as preventing metabolic and 
reproductive disorders in transition dairy cows.  
Yeast-based products  
Yeast-based products have been used in livestock animals for many years due to 
its beneficial effects, with the most common yeast species being Saccharomyces 
cerevisiae. The effects of yeast products in ruminants have been previously reviewed 
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from rumen characteristics and animal performance point of view (Fonty and 
Chaucheyras-Durand, 2006; Chaucheyras-Durand et al., 2008). Among the main effects 
observed, yeast improves growth and activities of ruminal microbial communities and, 
consequently, promotes positive effects on milk or meat production (Fonty and 
Chaucheyras-Durand, 2006).  Yeast can be beneficial to balance digestive microflora, 
promoting better animal health (Chaucheyras-Durand et al., 2008). However, the use of 
yeast appears to be more relevant when both animal and its rumen microbiota are 
challenged, for example, during a sudden nutritional change or stress period 
(Chaucheyras-Durand et al., 2008). Furthermore, yeast-based products from S. cerevisiae 
are commercially available in different forms: live, dead, a combination of both forms 
(live and dead), or yeast culture. 
Yeast culture  
Yeast culture is a complex fermentable yeast-based product that contains yeast 
biomass and fermentation metabolites, including vitamins, proteins, peptides, amino 
acids, nucleotides, lipids, organic acids, oligosaccharides, esters, and alcohols (Jensen et 
al., 2008). Yeast culture can also provide fermentable metabolites, minerals, and enzymes 
that can change the profile and physiology of ruminal bacteria (Chaucheyras-Durand et 
al., 2008; Ghazanfar et al., 2017). In addition, yeast culture may contain residual amounts 
of yeast biomass, providing mannooligosaccharides and glucans, which can promote an 
immunomodulatory effect (Jensen et al., 2008). 
Main effects and mode of action of yeast-based products 
Several mechanisms have been proposed to explain the mode of action of yeast in 
animal nutrition; however, the overall positive effect is the modulation and improvement 
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of the rumen microbial population. The main factors implicated in the beneficial effects 
of yeast are 1) oxygen uptake; 2) micronutrient supply; and 3) ruminal lactate 
metabolism; that will promote microbial establishment (Chaucheyras-Durand et al., 
2008).  Figure 1.2 summarizes the mode of action of yeast products at the rumen and 
animal level. 
Live yeast can scavenge oxygen, and as a result, promote a better anaerobic 
ruminal environment. Live yeast can interact with ruminal bacteria in a “micro-
consortium structure”, by promoting a localized anaerobiosis in freshly ingested particles 
(e.g., forages and starch) that may contain oxygen, thus benefiting bacterial digestion 
(Jouany, 2006). Live yeast uses oxygen to metabolize sugars and oligosaccharides, which 
results in end-products (e.g., ethanol, glycerol, and peptides) utilized by ruminal bacteria 
to stimulate growth and fermentation  (Jouany, 2006; Ghazanfar et al., 2017). The 
anaerobic environment promoted by live yeast improves growth and metabolism of 
cellulolytic species, given their high sensitivity to the presence of oxygen (Chaucheyras-
Durand and Fonty, 2009; Ghazanfar et al., 2017). Oxygen scavenging by live yeast can 
increase cellulolytic bacteria populations and the flow of microbial protein to the lower 
gastrointestinal tract, which will contribute to the metabolizable protein (Fonty and 
Chaucheyras-Durand, 2006). In support of the oxygen uptake theory, Newbold et al. 
(1996) reported that wild-type strains of S. cerevisiae were able to consume oxygen and 
stimulate bacterial activity in rumen-simulating fermenters. Lactate can accumulate 
rapidly in the rumen due to sudden changes to high carbohydrate diets. Volatile fatty 
acids (VFA) are one the end-products of ruminal fermentation. Lactate is considered a 
stronger acid than VFA (pKa 3.9 versus 4.7, respectively), and the accumulation of lactate 
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in rumen can lead to a more pronounced decrease in pH (Russell, 2002). The decrease in 
pH can render cows at risk of developing subacute ruminal acidosis (SARA). The effect 
of yeast supplements on maintain ruminal pH and preventing SARA has been attributed 
to a reduction in ruminal lactate production (Dias et al., 2018) while stimulating growth 
of lactate-utilizing bacteria (Callaway and Martin, 1997; Fonty and Chaucheyras-Durand, 
2006). Lactate-associated bacteria such as Megasphaera elsdenii, Anaerovibrio 
lipolytica, and Selenomonas ruminantium can utilize lactate as an energy source and 
produce a variety of end-products (Russell, 2002; Puniya et al., 2015). The lactate 
reduction caused by yeast supplementation has been reported by Pinloche et al. (2013), 
who demonstrated that live yeast supplementation was associated with greater lactate-
utilizing bacteria. This, in turn, promoted greater total VFA and ruminal pH while 
reducing lactate. In addition, the increase in lactic acid utilizer bacteria has been 
associated with better animal efficiency due to its metabolic pathway that utilizes lactate 
to produce propionate (Pinloche et al., 2013; AlZahal et al., 2014; Shabat et al., 2016). 
Taking together, the effects of live yeast on oxygen uptake, micronutrient supply, 
and pH stabilization may depend on the type of yeast or the diet of the animals. However, 
most of the yeast products can stabilize rumen pH (Desnoyers et al., 2009) by promoting 
an increase in cellulolytic (Fibrobacter and Ruminococcus) and lactate-utilizing bacteria 
(Megasphaera and Selenomonas) (AlZahal et al., 2014; Jiang et al., 2017b). Little is 
known about the positive effects of yeast-based products on the immune system in dairy 
cows. The effects of yeast cell wall components such as β-glucans and 
mannooligosaccharides have been reported as the main mechanisms to interact with the 
immune system. This has been well established since these two yeast cell wall 
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components can promote an immunomodulatory response (Goodridge et al., 2009; 
Korolenko et al., 2019). The β -glucan can activate macrophages, dendritic cells, 
neutrophils, natural killer cells, B and T lymphocytes, and increase phagocytosis and 
cytokine production (Kim et al., 2011). Mannooligosaccharides can regulate the 
inflammatory response by modulating the level of molecules released into the circulation 
during inflammation (Korolenko et al., 2019).  Yeast can modulate gene expression in 
porcine intestinal epithelial cells, by decreased the transcript and protein abundance of 
pro-inflammatory genes, including IL-6 and IL-8, during Escherichia coli exposure 
(Zanello et al., 2011). 
The mechanism behind the interaction between supplemented yeast, rumen 
epithelium, and innate immunity still unclear. This interaction can be partially attributed 
to better energy status promoted by positive effects on digestion or activation of the 
immune system by sensing yeast components (Lopreiato et al., 2020).  A recent in vitro 
study using ovine ruminal epithelial cells demonstrated that β-glucan could activate the 
immune system via Dectin-1 signaling pathway, suggesting a potential mechanism to 
explain this activation (Zhang et al., 2019). This mechanism was explained by β-glucan 
from S. cerevisiae upregulating β-defensin 1 (SBD1) in ovine ruminal epithelial cells via 
the Dectin-1–Syk–NF-κB axis, which can release a variety of cytokines, thereby 
promoting the innate immune function. Similar to β-glucan, the effects of mannan 
derived from S. cerevisiae have been reported in ovine cell culture models. For instance, 
mannan can induce β-defensin-1 expression via Dectin-2-Syk-p38 pathway in ovine 
ruminal epithelial cells (Jin et al., 2019). According to these findings in vitro, the immune 
activation by β-glucans and mannooligosaccharides in ovine ruminal epithelial cells is 
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due to the C-type lectin receptor involved in fungal recognition (Jin et al., 2019; Zhang et 
al., 2019). To our knowledge, there are no studies evaluating C-type lectin receptor on 
ruminal epithelium or immune cells in transition dairy cows. In transition dairy cows, 
Bach et al. (2018) reported that live yeast supplementation resulted in upregulation of 
genes (e.g., TLR4) related to inflammation and epithelial barrier in the ruminal 
epithelium, leading to a quicker response by innate and adaptive immunity.  
Yeast-based products in dairy cow performance   
In dairy cows, the effects of different yeast products have been reported across 
performance (Jiang et al., 2017a; Dias et al., 2018), rumen characteristics (AlZahal et al., 
2014; Jiang et al., 2017b; Zhu et al., 2017) and methane emission (Meller et al., 2019; 
Welty et al., 2019). However, there is a lack of consistency in response to yeast 
supplementation in dairy cows, which might be associated with the wide variety of 
configurations of yeast products and metabolites that can be incorporated in animal feeds. 
In addition, Piva et al. (1993) suggested that the stage of lactation, type of forage, feeding 
strategy, and the forage-to-concentrate ratio can affect the response to yeast 
supplementation in dairy cows. 
In a meta-analysis Robinson and Erasmus (2009) examined 22 lactation 
experiments with different S. cerevisiae-based yeast products and observed a 0.9 kg/d 
increase in milk production due to yeast supplementation. Desnoyers et al. (2009) 
summarized the findings from 110 papers and 157 experiments in ruminants, representing 
a broad range of yeast products and feeding conditions, reporting effects of yeast 
supplementation on dry matter intake, milk yield, rumen pH, rumen VFA, and organic 
matter digestibility. In a more recent meta-analysis, Poppy et al. (2012) reported that 
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yeast culture from S. cerevisiae could increase milk yield, milk fat, and milk protein in 
dairy cows. In the same meta-analysis, it was observed that yeast culture supplementation 
during early lactation increased DMI by 0.62 kg/d and energy-corrected milk (ECM) by 
1.65 kg/d.  
Yeast-based products in peripartal dairy cows   
Live yeast or yeast-based products supplementation has been evaluated in 
peripartal or early lactation dairy cows in terms of performance (Dann et al., 2000; Nocek 
et al., 2011; Shi et al., 2019; Stefenoni et al., 2020), rumen characteristics (Al Ibrahim et 
al., 2010; Bach et al., 2019), metabolic profile (Zaworski et al., 2014; Faccio-Demarco et 
al., 2019; Olagaray et al., 2019) and immune system function (Yuan et al., 2015b; 
Knoblock et al., 2019).  
Dann et al. (2000) observed that yeast culture improved DMI during the last 7 d 
before calving through the first 42 d of lactation, suggesting a potential benefit to the 
common decline in DMI during the transition period. Later, Shi et al. (2019) also 
observed effects on DMI, where the use of yeast culture increased feed intake around 
calving and feed efficiency postpartum. In early lactation dairy cows, yeast culture plus 
enzymatically hydrolyzed yeast improved production performance and mammary gland 
health (Nocek et al., 2011). In a recent study, Stefenoni et al. (2020) described that the 
use of yeast culture plus enzymatically hydrolyzed yeast did not affect DMI or milk 
production; however, they observed positive effects on milk components coupled with a 
decrease in days to first estrus. In contrast, other experiments did not observe 
improvements in performance, using live yeast or yeast culture (Al Ibrahim et al., 2010; 
Olagaray et al., 2019).  
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During the peripartal period, the rumen experiences a transient but important loss 
of microbial diversity, followed by a recolonization process due to diet, physiological, 
and environmental changes (Bach et al., 2019). The recolonization process occurs after 
calving, and it is characterized by a shift in bacterial populations that will affect the 
rumen kinetics and VFAs profile (Minuti et al., 2015). In addition, Minuti et al. (2015) 
observed changes in rumen characteristics, such as increased butyrate and decreased 
ruminal pH and acetate, which were partially explained by alterations in ruminal 
microbial species. Such alterations corresponded to increased Anaerovibrio lipolytica, 
Prevotella bryantii, and Megasphaera elsdenii, while decreased fibrolytic bacteria 
(Fibrobacter succinogenes and Butyrivibrio proteoclasticus). Al Ibrahim et al. (2010) did 
not observe major alterations in rumen parameters due to live yeast supplementation; 
however, they observed an increase in rumen protozoal counts, acetate molar proportion, 
and a reduction in rumen ammonia. In a recent study focused on rumen microbiota, Bach 
et al. (2019) reported that most of the effects of live yeast supplementation on rumen 
population were observed before calving and the taxonomic diversity after calving was 
more associated with feed intake, milk yield, and feed efficiency.  
Metabolic shifts during the transition period are common because of the 
adaptations associated with the transition period, such as NEB, reduced 
immunocompetence, and systemic inflammatory condition. Yeas culture supplementation 
can decrease serum cortisol concentrations and tended to increase serum concentrations 
of calcium, glucose, urea, and serum amyloid A during the first day after calving 
(Zaworski et al., 2014). This suggests that yeast culture may affect the metabolic and 
immunologic status of dairy cows in early lactation. Recent findings reported that yeast 
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culture supplementation led to shifts in cholesterol metabolism, tending to decrease 
hepatic cholesterol and increase plasma cholesterol (Olagaray et al., 2019), while other 
studies did not report the same effects (Piva et al., 1993). In a semi-extensive production 
system, supplementation with yeast culture plus enzymatically hydrolyzed yeast had no 
impact on the metabolic profile of dairy cows, even when these cows produced more 
milk (Faccio-Demarco et al., 2019).  
The connections between the ruminal effects of yeast products and subsequent 
systemic responses (e.g., immunometabolism) in transition dairy cows remain unclear. 
Yuan et al. (2015b) reported that yeast culture plus enzymatically hydrolyzed yeast 
supplemented at rates of 0, 30, 60, or 90 g/d from -21 to 42 d relative to calving linearly 
increased plasma anti-ovalbumin IgG levels following 3 ovalbumin challenges, which, in 
turn, indicates enhanced humoral immunity. Yuan et al. (2015b) also suggested that yeast 
supplementation in transition dairy cows could enhance mucosal immunity. Together, 
these effects could modulate uterine inflammatory signals and mammary gland health.  
Recently, Knoblock et al. (2019) reported the effects of yeast culture supplementation in 
dairy cows fed either a low-starch (22.1% starch) or high-starch (28.3% starch) diets 
during early lactation. They observed that yeast culture supplementation had an anti-
inflammatory effect, indicated by the lower serum haptoglobin, but no effects on adaptive 
immunity were detected. Knoblock et al., 2019 also concluded that a combination of 
yeast culture and low-starch diets during early lactation might reduce inflammation. In 
lactating dairy cows, yeast cell wall supplementation could increase mRNA expression of 
cytokines in peripheral blood mononuclear cells and enhance immune function (Aung et 
al., 2020).  
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RATIONALE AND OBJECTIVES 
The overall goal of this study was to understand the physiological responses to 
feeding a yeast culture supplement to transition dairy cows. Therefore, the objectives of 
this study were to evaluate the effects of a commercial yeast culture product on a) 
performance, blood biomarkers, rumen fermentation, and bacterial population; b) 
metabolism, inflammation, liver function, and immune function through blood 
biomarkers and gene expression in PMNL.  
 
CONCLUSION 
The success of the transition period will determine the profitability of the cow 
during that lactation (Drackley, 1999). Adequate nutrition and good management 
practices are essential for a successful transition period in dairy cows (Drackley et al., 
2006). The transition period is commonly associated with metabolic and immunologic 
challenges. For instance, factors associated with NEB, such as the rapid decrease in DMI 
before parturition and lipid mobilization from adipose tissue, are important points to 
consider when designing a dry cow management. During early lactation, cows are more 
susceptible to develop metabolic disorders, and the approaches of management should 
focus on it.   
Nutritional approaches have been developed through research to help cows 
achieve a smooth transition between late pregnancy to lactation. The interest in using 
yeast-based products derived from S. cerevisiae in dairy cows’ rations has increased in 
recent years. The utilization of these products appears to be relevant to improve 
performance and health. Yeast products are commercially available in different forms, 
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such as live, dead, a combination of both (live and dead), or yeast culture. Various 
mechanisms have been proposed to explain the mode of action of yeast in animal 
nutrition; however, the overall positive effect is the modulation and improvement of the 
rumen microbial population. The main factors implicated in the beneficial effects of yeast 
are 1) oxygen uptake; 2) micronutrient supply; and 3) ruminal lactate metabolism; that 
will promote microbial establishment (Chaucheyras-Durand et al., 2008). Besides the 
ruminal effects of live yeast, yeast cell wall components can be highly degradable in the 
rumen and promote an immunomodulatory effect (Jensen et al., 2008).  
Based on the above, the use of alternative nutritional strategies, such as yeast 
culture, can promote beneficial effects in dairy cows, especially during stressful periods 
such as the peripartal period. However, the optimal utilization of yeast-based products to 
confer the best physiological conditions to dairy cows for a smooth transition from 
pregnancy to lactation remains to be elucidated. The extensive amount of research and 
plethora of commercial yeast products and their combinations highlights the tremendous 
potential of yeast to fine-tune the metabolism and immune system of livestock animals. If 
decipher correctly, yeast technology applied to solve the inheritely complex 
immunometabolic challenges in the transition dairy cow model will provide the largest 




Figure 1.1 - Schematic representation of relationships among lipid metabolism in adipose 
tissue, liver, and mammary gland. Plus signs (+) indicate stimulatory effects, minus signs 
(−) indicate inhibitory effects. Dashed lines indicate processes that occur at low rates or 
only during certain physiological states. Abbreviations: Epi = epinephrine, NEFA = non-
esterified FAs; TG = triglyceride, VLDL = very-low-density lipoproteins. Source: Adapted 




Figure 1.2 - Schematic representation to explain the action of yeast in the rumen. Adapted 
















CHAPTER 2. EFFECTS OF FEEDING YEAST CULTURE PRODUCT ON 
PERFORMANCE, BLOOD BIOMARKERS, RUMEN FERMENTATION, AND 
RUMEN BACTERIA SPECIES IN PERIPARTAL DAIRY COWS 
 
ABSTRACT 
 Feeding yeast culture fermentation products has been associated with improved 
feed intake and milk yield in transition dairy cows. The objective of this study was to 
evaluate the effects of a commercial yeast culture product (YC; Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) on performance, blood biomarkers, rumen fermentation and 
bacterial population in dairy cows during the transition period until 50 DIM. Forty Holstein 
dairy cows were enrolled in a randomized complete block design from -30 to 50 DIM and 
blocked according to expected calving day, parity, previous lactation milk yield, and 
genetic merit. At -30 DIM, cows were assigned to either a basal diet plus 114 g/d of 
ground corn (CON; n = 20) or basal diet plus 100 g/d of ground corn and 14 g/d YC (n = 
20), fed as a top-dress. Cows received the same close-up diet from -30 until calving (1.39 
Mcal/kg DM and 12.3% CP) and lactation diet from calving to 50 DIM (1.60 Mcal/kg 
DM and 15.6% CP). Blood samples and rumen fluid were collected at various time points 
from -30 to 50 d relative to calving. Cows fed YC compared with CON had trend for an  
increased milk yield (+2.5 kg/d) and ECM (+3.2 kg/d). Lower SCC was observed in YC 
cows than CON. There was a diet × time interaction in NEFA and  BHB that could be 
attributed to a trend for greater NEFA and BHB in YC cows than CON at   7 DIM, 
followed by a lower NEFA in YC cows than CON at 14 and 30 DIM. Similarly, BHB 
tended to be lower in YC cows than CON at 30 DIM. This suggests yeast 
supplementation have a potential effect on postpartal metabolism. In the rumen, YC 
product contributes to mild changes in rumen fermentation, mainly increasing postpartal 
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valerate while decrease isovalerate. This was accompanied by alterations in rumen 
microbiota, including a greater abundance of cellulolytic (Fibrobacter succinogenes) and 
lactate-utilizing bacteria (Megaspheara elsdenii and Anaerovibrio lipolytica).  These 
results show an overall beneficial effect of supplementing yeast culture during the late 
pregnancy through early lactation, at least in terms of rumen environment and 
performance. 
Key words: transition cow, yeast culture, rumen bacteria 
 
INTRODUCTION 
The transition period has been defined as a critical period for dairy cows, 
characterized as 3 wk before and 3 wk after parturition (Drackley, 1999). This is a 
challenging period for dairy cows because of the lactogenesis, uterine involution, and 
metabolic and endocrine changes associated with negative energetic balance (Bradford et 
al., 2015) and often impairs the immune response (Trevisi and Minuti, 2018). Direct-fed 
microbials can be used as a nutritional alternative to improve health and performance 
during the transition between pregnancy and early lactation (Roche et al., 2013; Lopreiato 
et al., 2020). 
Yeast culture is a complex fermentable feed additive that contains: yeast cell walls 
(i.e., beta-glucans and mannan-oligosaccharides), vitamins, proteins, peptides, amino 
acids, nucleotides, lipids, organic acids, oligosaccharides, esters, and alcohols (Jensen et 
al., 2008). According Chaucheyras-Durand et al. (2008), the main effects of yeast products 
are related to rumen fermentation, benefiting key microbial populations and their 
metabolism, and consequently increasing fiber degradation and stabilizing rumen pH. 
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The beneficial effects of different live yeast or yeast culture-based products have 
been reported on the performance of dairy cows supplemented throughout the transition 
period or during early lactation only (Dann et al., 2000; Nocek et al., 2011; Shi et al., 2019). 
These effects have been further described in terms of rumen characteristics (Al Ibrahim et 
al., 2010; Bach et al., 2019), metabolic profile (Zaworski et al., 2014; Faccio-Demarco et 
al., 2019; Olagaray et al., 2019) and immune system function (Yuan et al., 2015b; 
Knoblock et al., 2019; Lopreiato et al., 2020). However, these cumulative data on yeast 
supplementation across transition cow studies are inconsistent and might be associated with 
the wide variety of configurations of yeast cultures or yeast fermentation metabolites used 
in such studies. 
The yeast culture evaluated in the current study was a concentrated form of yeast 
culture and fermentation metabolites originating from a S. cerevisiae yeast strain that is 
grown on a medium and dried on beneficial plant-based carriers. The hypothesis was that 
feeding this complex product during the transition period would affect performance and 
ruminal characteristics. The objective of this study was to evaluate the effects of a 
commercial yeast culture product (Cellerate Yeast Solutions®, Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) on performance, blood biomarkers, rumen fermentation, and 
bacterial population in dairy cows during the transition period until 50 DIM. 
 
MATERIAL AND METHODS 
Experimental Design and Dietary Treatments 
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota 
State University approved all the procedures for this study.  Forty late pregnant Holstein 
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dairy cows, including 34 multiparous and 6 primiparous cows, were used in a randomized 
complete block design and were blocked according to calving day, parity, previous 
lactation milk yield, and genetic merit.. During the dry period, the cows received the 
same close-up diet (1.39 Mcal of NEL/kg and 12.3% CP; Table 2.1) and at -30 d before 
expected calving date cows were assigned to the treatments. The treatments were top-
dressed as a control (CON; 114g/h/d ground corn; n = 20) or CON plus Culture Classic 
HD (YC; 100 g ground corn + 14g YC/h/d; n = 20). After parturition, all cows were fed 
the lactation basal diet (1.60 Mcal of NEL/kg and 15.56% CP; Table 2.1), as a total mixed 
ration, and the supplementation continued through 50 d postpartum.   
Animal Management  
Cows were enrolled in the experiment from mid-September 2018 to early April 
2019. Cows were fed using an individual gate system (American Calan, Northwood, 
NH), and intakes were recorded daily. Diets were formulated using the NDS Professional 
(Nutrition Dynamic System; RUMN Sas.) to meet requirements of the average cow in 
the group according to the NRC (2001) (Table 2.1). Dry matter (DM) of individual feed 
ingredients was determined weekly and diets were adjusted accordingly to maintain 
formulated DM ratios of ingredients in the total mix ratio (TMR). The cows were fed 
once daily before morning milking using a Data Ranger Tool 
(http://americancalan.com/code/template.cfm?page=3). The feed offered was adjusted 
daily to achieve a 5 to 10% refusals the following days. 
During the dry period, cows were housed in a bedded pack pen, and 3 d before 
expected calving date, cows were reallocated in individual pens bedded with straw until 
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parturition. On day 3, after calving, cows were moved to a lactation free-stall barn where 
they were receiving the same lactation basal diet until 50 d postpartum.  
Body weight was measured weekly for each cow in the afternoon at 13:00h. Body 
condition score (BCS) (scale 1= thin to 5= obese) was assigned by two individuals and 
the average score was used for statistical analysis.  
Feed and Milk Samples  
Individual samples of ingredients and TMR were collected weekly were frozen at 
-20°C after DM analysis and until further nutrient analysis. Composited samples for 
ingredients and TMR were analyzed for contents of DM, CP, NEL, NDF, ADF, using wet 
chemistry methods (Dairy One, Ithaca, NY).  
Cows were milked twice a day and milk yield was recorded at each milking until 
50 DIM. Consecutive morning and evening milk samples were collected 1 d/wk    during 
the experimental period. Composite milk samples were performed in proportion to milk 
yield   at each milking, preserved (Broad Spectrum Microtabs II, Advanced Instruments, 
Norwood, MA), and analyzed for fat, protein, lactose, solids, milk urea nitrogen (MUN) 
and somatic cell count  (SCC).The ECM was calculated based on milk yield and milk 
sample analysis as follows: ECM = [12.82 × fat yield (kg)] + [7.13 × protein yield (kg)] + 
[0.323 × milk yield (kg)] (Hutjens, 2010). Equations from NRC (2011) were used to 
calculate energy balance (EB) for each cow. The energy intake was determined using 
daily DMI multiplied by NEL density of the diet. Net energy of maintenance  was 
calculated as BW0.75 × 0.080. Requirements of NEL were calculated as NEL = (0.0929 × 
fat % + 0.0547 × protein % + 0.0395 × lactose %) × milk yield. The net energy 
requirement for pregnancy (NEP; Mcal/d) was calculated as NEP = [(0.00318 × day of 
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gestation − 0.0352) × (calf birth weight/45)]/0.218. The equation used to calculate 
prepartal EB (EBPRE; Mcal/d) was EBPRE = NEI − (NEM + NEP) and EBPRE (as % of 
requirements) = [NEI/ (NEM + NEP)] × 100. The equation used to calculate postpartal EB 
(EBPOST) was EBPOST (Mcal/d) = NEI − (NEM + NEL) and EBPOST (as % of requirements) 
= [NEI/(NEM + NEL)] × 100. 
Blood Collection and Analyses 
Blood was sampled from the coccygeal vein before morning feeding using a 20-
gauge vacutainer needle (Becton Dickinson, Franklin Lakes, NJ) at -30, -15, 7, 14, and 30 
d relative to parturition from a subset of multiparous cows (n=8 multiparous 
cows/treatment). Blood was collected into evacuated tubes (5 mL, BD Vacutainer, 
Becton Dickinson, Franklin Lakes, NJ) containing either serum clot activator or lithium 
heparin. After collection, tubes that contained lithium heparin were placed on ice and 
tubes with serum clot activator were kept at 21°C until centrifugation. Serum and plasma 
were obtained by centrifugation at 1,300 × g for 15 min at 21°C and 4°C, respectively. 
The aliquots of plasma were frozen at -80°C until further analysis.  
Plasma samples were analyzed for biomarkers of muscle body mass [e.g., 
creatinine and urea], metabolism [e.g., glucose, NEFA and BHB] and oxidative stress 
[e.g., reactive oxygen metabolites (ROM) and ferric reducing anti-oxidant power 
(FRAP)] using kits purchased from Instrumentation Laboratory (Lexington, MA) and the 
procedures were described previously (Trevisi et al., 2012; Batistel et al., 2016; Jacometo 





Rumen Fluid Collection and Analyses 
Rumen fluid (~50 mL) was sampled on -59, -29, 5, and 30 d relative to parturition 
from a subset of multiparous cows (n = 8 cows/treatment) via esophageal tubing. After 
discarding the first 200 mL of fluid to minimize saliva contamination, approximately 50 
mL of rumen fluid was collected. After collection, the rumen pH was immediately 
measured using a pH meter (Waterproof pH Test 30, Oakton Instruments, Vernon Hills, 
IL). Two aliquots of 10 mL were saved in a bottle containing either 200 µL of 50% 
sulfuric acid or 2 mL of 25% metaphosphoric acid and stored at -20°C until analysis of 
ammonia (NH3) and VFA respectively. Furthermore, 2 mL of rumen fluid sample was 
immediately frozen in liquid nitrogen followed by storage at -80°C until DNA isolation 
followed by relative abundance of bacteria species quantification via qPCR method. 
Ammonia and VFA 
Rumen fluid samples preserved with sulfuric acid and 25% meta-phosphoric acid 
were thawed and transferred into a 2mL microcentrifuge tube and centrifuged at 30,000 × 
g for 20 min at 4°C (Model 5403, Eppendorf, Hamburg, Germany). The supernatant of 
rumen fluid sample with sulfuric acid was used to analyze Ammonia-N concentration 
using the assay described by Chaney and Marbach (1962). VFA concentrations were 
measured in samples contained 25% metaphosphoric acid using an automated gas 
chromatograph (Model 689, Hewlett-Packard, Palo Alto, CA) equipped with a 0.25 mm 
i.d ×15 m capillary column (Nukol 24106-U, Sulpeco, Inc., Bellefonte, PA) and the 
internal standard used was 2-ethylbutyrate.  
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Ruminal Bacteria DNA Isolation and qPCR Amplification of 16S rDNA Genes 
 Ruminal bacteria DNA was isolated using the QIAmp Fast DNA Stool Mini Kit 
(Qiagen, Hilden, Germany) with modifications to the protocol described by Henderson et 
al. (2013). Briefly, 1mL of rumen fluid was centrifuged at 12,000 × g for 5 min and the 
supernatant was discarded. Pellet was resuspended in 1 mL of buffer EX, vortex, 
incubated in a heat block at 95°C for 5 min and centrifuged at 20,000 × g for 1 min. 
Then, 600 L of supernatant was transferred to a new microcentrifuge tube contained 25 
L of Qiagen Proteinase K, followed by addition of 600 L of Buffer AL. The mixture 
was vortexed for 15 s and incubated at 70 C for 10 min. After incubation, 600 L of 
96% molecular ethanol was added and vortexed. The mixture was transferred into a 
QIAamp mini spin column, and the subsequent steps were performed according to 
manufacturer’s procedures (Qiagen, Hilden, Germany). The DNA quantity and purity 
were measured using a NanoDrop spectrophotometer (ND 1000, NanoDrop Technologies 
Inc., Wilmington, DE) and the extracted DNA was standardized to 8 ng/µL for qPCR. 
The primer sets used in this study have been previously reported and validated 
(Table 2.2). The qPCR analysis was performed using 10 L of qPCR mixture containing 
4 L of sample DNA, 5 L of 1 x SYBR Green master mix (Applied Biosystems, 
Waltham, MA), 0.4 µL of 10 µM each for forward and reverse primers, and 0.2 µL of 
DNase-RNase-free water in a MicroAmp Optical 384-well reaction plate (Applied 
Biosystems). Each sample was run in triplicate and the qPCR reactions were performed 
in a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems) using the same 
conditions described by Grazziotin et al. (2020). A geometrical mean of two universal 
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bacteria primers was used to calculate the relative abundance of bacterial species 
(Abdelmegeid et al., 2018). 
Statistical Analysis 
Data were analyzed as repeated measures with the MIXED procedure of SAS 
according to the following model: 
𝑌𝑖𝑗𝑘𝑙𝑚 = 𝜇 + 𝐷𝑖 + 𝑃𝑗 + 𝐷𝑃𝑖𝑗 + 𝐵𝑘 + 𝐶𝑖𝑗𝑘𝑙 + 𝑇𝑚 + 𝐷𝑇𝑖𝑚 + 𝐷𝑃𝑇𝑖𝑗𝑚 + 𝑒𝑖𝑗𝑘𝑙𝑚 
Where 𝑌𝑖𝑗𝑘𝑙𝑚is the dependent, continuous variable; 𝜇 is the overall mean; 𝐷𝑖 is the 
fixed effect of the ith diet (i = 1 and 2); 𝑃𝑗 is the fixed effect of the jth parity (j = 1, 2, 3); 
𝐵𝑘 is the random effect of the kth block (k = 1, …20); 𝐶𝑖𝑗𝑘𝑙 is the random effect of lth cow 
nested within the ith treatment, the jth parity, and the kth block (l = 1,…, 𝑛𝑖𝑗𝑘); 𝑇𝑚 is the 
fixed effect of the mth time (d or wk) of the experiment (m = 1,… n); 𝐷𝑇𝑖𝑚 is the fixed 
effect of the ith treatment by the mth time of the experiment interaction; 𝐷𝑃𝑇𝑖𝑗𝑚 is the 
fixed effect of the ith treatment by the jth parity by the mth time of the experiment 
interaction; and 𝑒𝑖𝑗𝑘𝑙𝑚 is the residual error. Parity effect was removed from the model any 
time it was nonsignificant (P > 0.05). Blood biomarkers and rumen fluid data, including 
pH, VFA, NH3, and relative abundance of microbial species were analyzed at various time 
points that were not equally spaced; therefore, an exponential correlation covariance 
structure SP (POW) was used for repeated measures. Blood biomarkers and relative 
abundance of microbial species were log-scale transformed if needed to comply with 
normal distribution of residuals. Blood biomarkers and rumen fluid data on -30 and -59 d, 
respectively, were used as a covariate. The covariate of previous 305-d milk yield was 
maintained in the model for all variables for which it was significant (P < 0.05). Statistical 




Peripartal DMI, BW, and BCS  
Main effects and interactions for prepartal and postpartal BW, BCS, DMI, DMI as 
percent BW, and EB are presented in Table 2.3. Neither the prepartal nor postpartal BW, 
BCS, and DMI, DMI as %BW, and EB were affected (P ≥ 0.23) by dietary treatments.  
Milk Production and Composition  
 Main effects and interactions for postpartal production variables and milk 
efficiency in terms of Milk/DMI and ECM/DMI are presented in Table 2.4 and Figure 
2.1. The SCC was lower (P < 0.01) in YC fed cows than CON. A trend for a diet effect 
was observed in milk yield (P = 0.13) and ECM (P = 0.07), where YC cows produced 2.5 
kg/d and 3.2 kg/d more than CON, respectively. Also, similar to milk yield, a trend (P = 
0.11) was observed for a greater milk fat yield in YC cows when compared to CON. Milk 
efficiency in terms of milk/DMI was not affected (P = 0.52) by dietary treatments, and 
milk efficiency in terms of ECM/DMI even though it was ca. 0.10 greater in YC cows 
than CON, this effect did not reach statistical significance (P = 0.18) 
Rumen Fermentation 
Main effects and interactions for rumen fermentation characteristics are presented 
in Table 2.5. There was a D × T interaction observed in VFA concentrations of 
isovalerate (P = 0.05) and valerate (P = 0.04) (Figure 2.2). The D × T in valerate was 
mainly associated with greater (P = 0.01) concentration in YC cows than CON at 5 DIM. 
In contrast to valerate, the D × T in isovalerate was reflected in lower (P < 0.01) 
concentrations in YC cows than CON at -29 DIM. The latter was reflected in lower (P = 
0.02) isovalerate in YC cows in comparison to CON. 
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Abundance of Ruminal Bacteria 
Main effects and interactions for the relative abundance of microbial species in 
rumen fluid are presented in Table 2.6.  There was a D × T (P ≤ 0.05) on the relative 
abundance of Prevotella albensis, Prevotella bryantii, Prevotella ruminicola, and 
Succinivibrio dextrinosolvens (Figure 2.3). Similarly, a trend for a D × T was observed in 
Selenomonas ruminantium (P = 0.11) and Succinimonas amylolytica (P = 0.12) (Figure 
2.3). The D × T observed in P. albensis was associated with a greater (P = 0.03) 
abundance of this bacterium in YC cows than CON at 30 DIM. The D × T in P. 
ruminicola resulted in lower (P = 0.01) abundance of this bacterium in YC cows in 
comparison to CON at 5 DIM. Similar to P. ruminicola, S. ruminantium tended (P = 
0.12) to be lower in YC cows in comparison to CON at 5 DIM. The D × T in S. 
dextrinosolvens (P = 0.02) and P. bryantii (P = 0.04)   resulted in a similar pattern, where 
lower in YC cows than CON at -29 DIM. Contrary to S. dextrinosolvens and P. bryantii, 
S. amylolytica had a greater (P = 0.01)  abundance in YC cows than CON at -29 DIM. 
There was a greater relative abundance of Megaspheara elsdenii (P = 0.05) and S. 
amylolytica (P = 0.03) in YC cows than CON (Table 2.6). In contrast to M. elsdenii and 
S. amylolytica, P. brevis abundance was lower (P < 0.01) in YC cows in comparison to 
CON. In addition, there was a trend for greater abundance of Anaerovibrio lipolytica (P 
= 0.12) and Fibrobacter succinogenes (P = 0.09) in YC cows than CON (Figure 2.4).  
Blood Biomarkers 
Main effects and interactions for blood biomarkers of muscle body mass, 
metabolism, and oxidative stress are presented in Table 2.7. There was a D × T (P = 0.02) 
in NEFA and a trend (P = 0.13) in BHB (Figure 2.5). The D × T in NEFA resulted in 
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lower NEFA in YC cows than CON at -15 (P = 0.05), 14 (P = 0.05), and 30 d (P = 0.02)  
relative to parturition, while a tendency (P = 0.12) for greater NEFA was observed in YC 
cows than CON at 7 DIM. The latter effects can be attributed to a trend for overall lower 
NEFA (P = 0.10) in YC cows than CON. Similar to NEFA, the D × T  in BHB was 
associated with a tendency for a greater (P = 0.10) BHB in YC cows than CON at 7 DIM, 
followed by a trend for lower (P = 0.11) BHB in YC cows than CON at 30 DIM.  
 
DISCUSSION 
Effects on DMI, BW, and BCS 
Peripartal dairy cows commonly experience a decline in DMI around parturition. 
(Drackley, 1999). This decline in DMI results in low energy intake, which has been 
associated with BCS and hormonal changes around parturition (Ingvartsen and Andersen, 
2000). As a result of this decrease in energy intake, dairy cows enter a negative energy 
balance (NEB) that is exacerbated by the substantial increase in energy demands to 
sustain milk production after calving. Dairy cows respond to NEB by mobilizing lipid 
from adipose tissue in the form of NEFA, to cope with energy demands in early lactation 
(Contreras and Sordillo, 2011). Because of these reasons, it is typical to observe a 
decrease in BCS and BW in dairy cows during early lactation.  
Yeast culture has supplemented to dairy cows with the aim of improving 
performance and health (Poppy et al., 2012). Yeast culture supplementation has been 
reported to affect DMI in transition dairy cows(Olagaray et al., 2019; Shi et al., 2019; 
Stefenoni et al., 2020). For instance, Shi et al. (2019) reported a trend for an increase in 
DMI during the first week after calving in dairy cows supplemented with 19 g/d of S. 
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cerevisiae fermentation product. Similarly, Dann et al. (2000) observed improvements in 
DMI during the first 42 DIM in peripartal Jersey dairy cows fed 60g/d of a yeast culture 
product. In the current study, yeast culture supplementation did not statistically affect 
peripartal DMI, and by extension, no effect on BW or BCS was observed around 
parturition.  
Milk Production and Milk Components  
There is a lack of consistency on the milk yield response to yeast supplementation 
in dairy cows. This is predicated on the multiple forms (e.g., active and dead), packing, 
and metabolites that can be incorporated in commercial yeast supplements. For instance, 
feeding yeast culture products has been observed to increase milk yield between 3.3 and 
5.2 kg/d in transition and mid-lactation dairy cows (Zaworski et al., 2014; Dias et al., 
2018).  Robinson and Erasmus (2009) reviewed several yeast culture studies in dairy 
cows and reported that overall yeast supplementation has a positive effect on milk yield 
(~ 0.9 kg/d). In contrast, some studies reported a lack of effect on milk production in 
transition dairy cows (Yuan et al., 2015a; Olagaray et al., 2019; Stefenoni et al., 2020). A 
positive effect on milk production was observed in YC cows with an increase of 2.5 kg/d, 
which was within the range of milk yield improvement observed in previous studies 
feeding yeast supplements.  
Yeast culture supplementation has been observed to effect milk fat yield in early 
and mid-lactation dairy cows (Dias et al., 2018; Perdomo et al., 2020). Olagaray et al. 
(2019) observed 0.13kg/d increase in milk fat yield at 4 and 5 wk postpartum, feeding 19 
g/d of yeast culture during the peripartal period, which was similar to the 0.16 kg/d 
increase in milk fat yield observed in YC cows in comparison to CON. Diets containing 
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relatively high levels of unsaturated fats and starch have been associated with milk fat 
depression in dairy cows due to increased flow of trans FAs from ruminal fermentation 
(Bradford and Allen, 2004). In this context, Longuski et al. (2009) reported that lactating 
dairy cows supplemented with a yeast culture had a higher degree of resistance to milk 
fat depression during a short-term dietary challenge with fermentable starch. This can be 
partially ascribed to yeast maintaining a favorable rumen fermentation for cellulolytic 
bacteria which is the primary source of ruminal acetate. Therefore, yeast supplementation 
may indirectly promote a stable supply of acetate for milk fat synthesis by maintaining a 
favorable population of cellulolytic bacteria (Ghazanfar et al., 2017).  
The benefits of yeast culture supplementation on milk performance paramenters, 
in the present study were reflected in ECM and milk efficiency in terms of ECM/DMI. 
These results agree with those of Perdomo et al. (2020) and Dias et al. (2018), where 
yeast products caused an increase in ECM. Perdomo et al. (2020) observed that under 
heat stress conditions, lactating cows fed with 1g of live yeast had an increase in ECM 
and feed efficiency measured as ECM/DMI, and such effects were attributed to 
improvements in crude protein and NDF digestibility. According to Dias et al. (2018), 
supplementation of yeast culture from S. cerevisiae could increase ECM in lactating cows 
fed diets varying in starch content. In contrast, others did not  observed positive effects in 
ECM in transition dairy cows supplemented with yeast derived from S. cerevisiae (Yuan 
et al., 2015a; Stefenoni et al., 2020). The fermentable products present in the YC product 
may have improved nutrient utilization by ruminal bacteria and consequently allowed a 
higher milk efficiency in YC fed cows.  
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Improvements in udder health, in terms of SCC, have been observed when 
feeding yeast culture products to dairy cows. For instance, Nocek et al. (2011) tested a 
yeast culture product alone or in combination with an enzymatically hydrolyzed yeast fed 
to dairy cows from calving to 14 wk postpartum, and this combination resulted in lower 
SCC through the first 14 weeks of lactation.(Zaworski et al., 2014). reported positive 
effects on SCC during the first 4 wk postpartum, when supplementing different dosages 
of S. cerevisiae fermentation product. Those effects were attributed to a potential 
activation of the animal’s immune system at the gut level by antigenic exposure in the 
form of β-glucans and mannan-oligosaccharides presented in some yeast products.  
Besides a systemic activation of the immune system as described by Nocek et al. (2011), 
the action of β-glucans has been tested at the local level during a mastitis induction 
(Waller et al., 2003). Waller et al. (2003) evaluated the effects of an intramammary 
infusion of β-1,3-glucan in dairy cows under a chronic subclinical mastitis model induced 
by Staphylococcus aureus. They did not observe any benefical effects of β-1,3-glucan on 
reducing subclinical mastitis. However a tendency to increase milk lymphocytes after β-
1,3-glucan infusion was observed, suggesting that, to some extent, β-1,3-glucan may 
stimulate a better local inflammatory response by increasing immune cell recruitment.   
Rumen Fermentation Parameters 
Dietary carbohydrates are fermented by ruminal bacteria, fungi, and protozoa into 
end products, including VFA (e.g., acetate, propionate, and butyrate) that make up for 
nearly 50% of the energy requirements for ruminants (Puniya et al., 2015). Desnoyers et 
al. (2009) reported in a meta-analysis that yeast supplementation increased total VFA 
concentration in domesticated ruminant species. Zhu et al. (2017) reported a positive 
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effect on total VFA when dairy cows were supplemented with S. cerevisiae fermentation, 
which was associated with a stimulatory effect on rumen microbial population, including 
cellulolytic bacteria. In the current study, total VFA production was not affected by yeast 
culture supplementation.   
The normal transition of dairy cows from late pregnancy into lactation is 
predicted on the cow’s ability to adapt to a postpartal lactation diet, which leads to 
increase  ruminal butyrate and valerate, while other VFAs such as isobutyrate and 
isovalerate remained unchanged (Minuti et al., 2015). The primary ruminal VFAs (i.e., 
acetate, propionate, and butyrate) seem to be less responsive to yeast supplementation in 
transition dairy cows  (Robinson and Garrett, 1999; Kumprechtova et al., 2019). Like in 
transition dairy cows, yeast culture and live yeast culture supplementation in mid-
lactation dairy cows did not elicit an effect on acetate, propionate, and butyrate (Dias et 
al., 2018, Meller et al., 2019). In agreement with those data, our results showed 
supplementing YC during the transition period did not influence VFA concentrations.  
Ruminal isoacids comprised of isobutyrate, 2-methylbutyrate, isovalerate, and 
valerate have been found to increase in response to yeast culture supplementation 
(Andries et al., 1987). For instance, in an experiment testing incremental levels of 
concentrate plus yeast culture supplementation (1g/kg of TMR as fed), yeast culture was 
shown to increase the concentration of isobutyrate and isovalerate regardless of 
concentrate level in the diet in cannulated Holstein dairy heifers (Lascano and Heinrichs, 
2009). Lactating dairy cows fed with a high dose of inactivated yeast increased the molar 
proportion of valerate, compared with control cows (Jiang et al., 2017a), which is 
consistent with the increase in valerate in YC cows at 5 DIM in the current study. An 
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alternative explanation for the increase in valerate could be associated with the greater M. 
elsdenii in YC cows, which was more evident postpartum (Figure 2.4 C). The latter is 
based on the fact that M. elsdenii can ferment L-lactate into propionate and subsequently 
valerate (Weimer and Moen, 2013). In addition, live yeast supplementation increased the 
concentration of isovalerate in early lactation dairy cows under heat stress conditions 
(Garcia Diaz et al., 2018; Perdomo et al., 2020). Similar findings for isovalerate were 
observed in the current study, where this isoacid increased in YC cows in early lactation. 
However, others have observed a lack of response of valerate and isovalerate 
concentration to supplementation of active dry S. cerevisiae in cannulated lactating dairy 
cows (AlZahal et al., 2014). Interestingly, Harrison et al. (1988) and coworkers observed 
a decrease in molar proportion of isovalerate while valerate increased in lactating cows 
fed a yeast culture supplement, and this effect was attributed to lower ruminal pH. The 
positive effects of yeast in ruminal valerate concentrations can be associated with 
changes in metabolic activities of ruminal bacteria, including amylolytic, cellulolytic, and 
lactate-utilizer populations. For instance, ruminal degradation of proteins by amylolytic 
bacteria commonly leads to production of isoacids (Dawson et al., 1990), while the 
fermentation pathway of lactate by ruminal bacteria may lead to the production of 
valerate (Weimer and Moen, 2013). These isoacids are required for most cellulolytic 
bacteria to degrade fiber, underscoring the essential role of isoacids for fiber digestibility 
(Liu et al., 2009).  
Yeast Culture and Ruminal Bacteria Species  
In transition dairy cows, rumen microbial populations are expected to change 
around parturition, which can be attributed to a natural adaptation of rumen microbes to a 
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lactating cow diet after calving. Minuti et al. (2015) reported diet changes after calving 
could result in a decrease in fiber digesting bacteria. According to Lima et al. (2015), the 
main differences between prepartal and postpartal bacterial populations encompass 
changes in cellulolytic and amylolytic bacteria followed by variations in other uncultured 
bacteria species for which a ruminal function remains unknown.  
The rumen environment is malleable, to some extent, and positive modifications 
can affect bacteria population and, by extension, its fermentation products, leading to 
improved performance and nutrient utilization in ruminants (Ghazanfar et al., 2017). 
Different mechanisms have been proposed to explain the action of yeast in the rumen. 
According to Jouany (2006), live yeast can interact with ruminal bacteria in a “micro-
consortium structure”, by promoting a localized anaerobiosis in freshly ingested particles 
(e.g., forages and starch) that may contain oxygen, thus benefiting bacterial digestion. 
Yeast uses oxygen to metabolize sugars and oligosaccharides, which results in end-
products (e.g., ethanol, glycerol, peptides, and amino acids) utilized by bacteria 
associated with yeast (Jouany, 2006). In addition, yeast culture products provide 
mannooligosaccharides and glucans present in the yeast cell wall that can be highly 
degradable in the rumen, as well as fermentable metabolites, minerals, and enzymes that 
can change the profile and physiology of ruminal bacteria, stimulating the growth of 
cellulolytic, amylolytic, and proteolytic bacteria (Chaucheyras-Durand et al., 2008; 
Ghazanfar et al., 2017; Jiao et al., 2019).  
The impact of yeast culture products on ruminal bacteria sbudance have been 
evaluated in lactating dairy cows (AlZahal et al., 2014; Zhu et al., 2017; Jiao et al., 2019) 
and transition dairy cows (Bach et al., 2019). There were positive effects in bacterial 
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populations in YC cows in the current study, mainly by increasing lactate and fiber 
digesting bacteria.  Similar to the current study, early lactating dairy cows supplemented 
with live yeast presented a greater abundance of lactate-utilizing bacteria (Megasphaera) 
and fiber digesting bacteria (Fibrobacter) (Pinloche et al., 2013). 
Minuti et al. (2015) observed a decrease in postpartal F. succinogenes abundance 
in transition dairy cows, primarily driven by high grain content in the lactation diet. 
Strains of S. cerevisiae have been reported to increase the abundance and activity of fiber 
digesting bacteria in rumen, such as Fibrobacter spp. (Jiang et al., 2017b). A trend (P = 
0.09) for a greater F. succinogenes abundance in YC cows compared to CON was 
observed, and such effect was more evident at 30DIM (Figure 2.4B). A more pronounced 
effect for greater F. succinogenes was observed by AlZahal et al. (2014)  in cannulated 
lactating dairy cows fed with active dry S. cerevisiae. A similar response was reported by 
Zhu et al. (2017), where F. succinogenes increased linearly in lactating dairy cows 
receiving incremental amounts (0, 60, 120, and 160 g/d) of S. cerevisiae fermentable 
products. In contrast, other studies in vitro and in vivo did not observe a yeast effect in F. 
succinogenes abundance (Mullins et al., 2013; Jiao et al., 2019). Yeast culture used in the 
current experiment contained live yeast, which could have promoted localized 
anaerobiosis, and, in turn, this could partially explain the trend for a greater abundance of 
F. succinogenes. 
Lactate-associated bacteria such as Megasphaera elsdenii and Anaerovibrio 
lipolytica can utilize lactate as an energy source and, consequently, slower growth rates 
of these bacteria are observed in low carbohydrate diets (Russell, 2002; Puniya et al., 
2015). Increased abundance of M. elsdenii and A. lipolytica has been observed in 
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transition dairy cows after calving, which was attributed to greater DMI and starch 
digestibility (Minuti et al., 2015). Similarly, live yeast supplementation has been reported 
to increase ruminal abundance of M. elsdenii (Ogunade et al., 2019) and A. lipolytica 
(AlZahal et al., 2014).In the present study, lactate was not evaluated, but M. elsdenii and 
A. lipolytica increased after calving, which is consistent with greater starch content in 
lactation diets. Additionally, the increase in the abundance of these bacteria in YC cows 
was more pronounced at 30 DIM (Figure 2.4A and 2.4C), suggesting that these bacteria 
were affected by yeast supplementation beyond the expect increased due to greater starch 
content in the lactation diet.  
Abdelmegeid et al. (2018) observed a higher abundance of S. dextrinosolvens 
during prepartum than postpartum, and S. amylolytica tended to follow the same pattern. 
In contrast, we observed no change over time in both bacteria, regardless of treatment 
(Figure 2.3E and 2.3F). These data are conflicting with these bacterias’s known starch-
degrading function (Russell, 2002), which implies that such bacteria abundance should 
increase postpartum. In contrast to these findings,  AlZahal et al. (2014) did not report a 
change in population of either S. amylolytica and S. dextrinosolvens when supplementing 
lactating dairy cows with active dry Saccharomyces cerevisiae. There was a prepartal 
increase of S. amylolytica with a contrasting decrease of S. dextrinosolvens in YC cows 
compared to CON. These effects on S. amylolytica and S. dextrinosolvens took place 
within 24 hours after initial supplementation with YC (-30 DIM), which render these 




Prevotella species can use a variety of substrates, such as starch, hemicellulose, 
pectin, β-glucans, and proteins, to produce acetate, propionate, succinate, and formate 
(Russell, 2002). The presence of Prevotella spp. in rumen across a variety of diets 
indicate the substantial metabolic diversity of this genus (Zeineldin et al., 2018). 
According to Stevenson and Weimer (2007), bacteria population of the genus Prevotella 
spp. are the most dominant bacteria in rumen, but only a small percentage is composed of 
P. bryantii, P. brevis, and P. ruminicola in lactating dairy cows fed with a normal TMR 
diet. This was later confirmed by Lima et al. (2015), showing that Prevotella is the most 
abundant bacterium in transition cows. 
In the current study, different responses due to YC supplementation were 
observed for P. albensis, P. bryantii, P. brevis, and P. ruminicola, confirming the 
metabolic diversity of this genus in the rumen. Supplementation of active dry S. 
cerevisiae reduced the population of P. albensis, and no effects were observed in P. 
bryantii and P. brevis in cannulated lactating dairy cows  (AlZahal et al., 2014). Our 
findings showed a greater abundance of P. albensis in YC cows at 30DIM (Figure 2.3 A), 
suggesting that YC supplementation coupled with an eventual adaptation to the lactation 
diet promoted an increase of this bacterium. P. bryantii was lower in cows supplemented 
with YC at -29 DIM, which seems to be similar to S. amylolytica and S. dextrinosolvens, 
where such effect might be transient as a 24 h response to YC supplementation. Overall, 
P. bryantii increased postpartum regardless of dietary treatments (Figure 2.3 B), which 
was a similar pattern observed by Minuti et al. (2015). Subacute ruminal acidosis induced 
via grain or alfalfa pellets cause a differential response among the Prevotella genus, 
specifically, P. ruminicola and P. albensis, which further underscore the metabolic 
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diversity of this genus (Khafipour et al., 2009). Our results suggest that Prevotella spp. 
evaluated in this study behave differently due to the YC supplementation, which is in line 
with previous differential response across Prevotella spp. An alternative explanation for 
the differential abundance among Prevotella spp. can be related to their ability to use 
signaling molecules such as N-Acyl homoserine lactones to communicate between 
bacteria in an orchestrated effect to coordinate bacterial population density, also known 
as quorum sensing (Won et al., 2020). Interactions through quorum sensing have been 
evaluated between yeast and bacteria (Proust et al., 2020). However, the specific 
mechanisms and interactions between YC products and ruminal bacteria such as 
Prevotella spp. remains unclear.  
Taken together, we observed that yeast culture supplementation promoted changes 
in rumen bacteria species across cellulolytic, amylolytic, and lactate-utilizer populations. 
These effects seem to have promoted beneficial rumen fermentation, at least in terms of 
valerate, which might have promoted better fiber digestion. The researchers speculate that 
the presence of lactate-utilizer bacteria can be helpful during the periods where the diet 
changes abruptly, such as the transition period. The abrupt change from a high-fiber diet 
prepartum to a lactation diet postpartum containing large amounts of fermentable 
carbohydrates can commonly lead to decreased pH, altering ruminal bacteria population 
and predisposing transition dairy cows to metabolic disorders. 
Blood Biomarkers  
During the transition period, dairy cows experience a reduction in energy balance, 
and lipid mobilization becomes a physiological adaptation mechanism to offset or 
compensate the NEB (Contreras and Sordillo, 2011). Lipid mobilization is associated 
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with hormonal changes around parturition, and it is commonly characterized by an 
excessive lipolysis rate over lipogenesis (Bradford et al., 2015). The main product of 
triglyceride hydrolysis in adipose tissue during lipid mobilization is NEFA, and it and 
serves as an alternative energy substrate for most tissues (Contreras and Sordillo, 2011). 
Blood NEFA reflects the level of NEB in transition dairy cows, and greater NEFA is 
commonly associated with fatty liver syndrome and increased production of ketone 
bodies. (Ingvartsen and Andersen, 2000; Ingvartsen, 2006). During NEB, the liver 
exceeds its capacity for oxidizing NEFA, which leads to partial oxidation of NEFA and, 
consequently, increasing BHB synthesis (Ingvartsen and Andersen, 2000). The latter is 
released into the bloodstream and serves as fuels for other tissues (Ingvartsen and 
Andersen, 2000). Minuti et al. (2015) detected lower prepartal NEFA and BHB, followed 
by a rapid increase after parturition, with the highest concentrations at 10 and 20 DIM.  
Inconsistent responses on blood NEFA and BHB have reported when feeding 
yeast culture products to transition dairy cows (Al Ibrahim et al., 2010; Yuan et al., 
2015a; Faccio-Demarco et al., 2019). For instance, Al Ibrahim et al. (2010) supplemented 
transition dairy cows with live yeast, and no effects were observed in NEFA and BHB. 
Similarly, Faccio-Demarco et al. (2019) supplemented 28 g/d of yeast culture plus 
enzymatically hydrolyzed yeast of S. cerevisiae to transition dairy cows and they did not 
observe differences in NEFA and BHB levels. Transition dairy cows fed with S. 
cerevisiae in combination with two Enterococcus strains from -21 to 70 d relative to 
parturition had lower postpartal NEFA and BHB concentrations after 8 and 22 DIM, 
respectively (Nocek et al., 2003). Yuan et al. (2015a) reported that a combination of live 
yeast culture plus enzymatically hydrolyzed yeast at the rate of 0, 30, 60, and 90 g/d from 
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-21 to 42 d relative to parturition cause an overall postpartal increase in BHB in yeast fed 
cows regardless of the level of supplementation.  
A postpartal increase in NEFA and BHB in YC cows was observed with the 
highest concentrations at 7 DIM. These responses were similar to those observed in 
transition dairy cows diagnosed with subclinical ketosis (Mezzetti et al., 2019) with 
maximal NEFA and BHB values at 7 DIM. However, the levels of NEFA and BHB (0.77 
and 0.72 mmol/L, respectively) in YC cows were much lower than those observed by 
Mezzetti et al. (2019). The latter suggests that the level of lipid mobilization in YC cows 
was not conducive to subclinical ketosis development. In addition, we observed that 
NEFA and BHB in YC cows declined more sharply after 7 DIM than CON cows. The 
reasons underlying this observation are unclear but suggest a potential effect of yeast 
product on lipid metabolism in transition dairy cows.  
 
CONCLUSIONS 
Yeast culture products have been fed to peripartal dairy cows for many years to 
improve milk yield and milk efficiency. The findings of this study revealed that YC 
promoted positive responses on performance, such as milk yield, SCC, and ECM. In the 
rumen, YC contributed to increased valerate soon after calving. The latter was 
accompanied by increments in rumen microbiota populations such as cellulolytic and 
lactic acid-utilizing. The supply of the yeast culture product and its fermentation 
metabolistes in rumen, could be a source of substrates for ruminal bacteria that can 
promote improvements in fermentable characteristics and optimize the relative 
abundance of microbial species. In addition, the yeast culture product may influenced 
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lipid metabolism in transition dairy cows, but this mechanism remains to be elucidated. 
The results describe an overall beneficial effect of supplementing YC during the 
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Table 2.1 - Ingredient composition of diets during the close-up (-30d to expected calving) 
and early lactation periods. 
Component 
 Diet 
 Close-up Lactation 
Ingredient, % DM1    
   Corn silage  37.5 36.31 
   Alfalfa silage  ----   8.71 
   Alfalfa hay  ---- 15.97 
   Grass Hay  23.9 ---- 
   Cotton seed  ----   8.25 
   Wheat straw  12.6 ---- 
   Soy best   10.5 ---- 
   Corn grain ground fine    3.1 16.07 
   Soybean meal      4.67   3.65 
   Distillers grains dry  ----   3.66 
   Animate3       3.72 ---- 
   Wheat midds  ----   3.65 
   Calcium carbonate      2.61   1.00 
   Calcium phosphate Di      0.52 ---- 
   Sodium bicarbonate  ----   0.91 
   Energy booster 1002  ----   0.91 
   Salt white      0.19   0.34 
   Magnesium oxide      0.21   0.16 
   Urea 281% CP  ----   0.11 
   JPW Dairy Vitamin Premix4      0.13   0.10 
   JPW Dairy TM Premix5      0.10   0.10 
Dairy VTM      0.14 ---- 
   Mepron  ----   0.04 
   Vitamin E, 20000 UI/lb      0.10   0.04 
   Biotin 1%  ----   0.01 
   Rumensin 90      0.01   0.01 
Chemical analysis    
   DM, %  49.81 50.61 
   NEL, Mcal/ kg DM    1.54   1.60 
   CP, % DM  12.31 15.56 
   NDF, % DM  46.39 38.55 
   ADF, % DM  28.78 25.83 
   DCAD, mEq/100 g  -9.70 -- 
1Ingredients included in the ration formulated by using Spartan Dairy Ration Evaluator 3.0 
2 Animate was used as the sole DCAD anion source.  
3 Energy Booster 100 (MSC, Carpentersville, IL) 
4Contained: 25.8 % Ca (DM basis) 1,545 IU/kg of Vitamin A, 387 IU/kg of Vitamin D, and 4,826 IU/kg of Vitamin E 
(JPW Nutrition, Sioux Falls, SD). 
5Contained: 11.7 % Ca (DM basis), 1.96 % S, 10,527 mg/kg of Fe, 63,158 mg/kg of Zn, 12,632 mg/kg of Cu, 63,158 




Table 2.2 - Species-specific primers used in real-time qPCR assay for the quantification 
of selected rumen bacteria population. 
Target bacterial species  Primer sequence (5’- 3’) Reference 
Anaerovibrio lipolytica Fa GAAATGGATTCTAGTGGCAAACG (Abdelmegeid et al., 2018) 
 Rb ACATCGGTCATGCGACCAA 
Butyrivibrio fibrisolvens F ACACACCGCCCGTACCA (Klieve et al., 2003) 
 R TCCTTACGGTTGGGTCACAGA 
Butyvibrio proteoclasticus F GGGCTTGCTTTGGAAACTGTT (Abdelmegeid et al., 2018) 
 R CCCACCGATGTTCCTCCTAA 
Eubacterium ruminantium F CTCCCGAGACTGAGGAAGCTTG (Abdelmegeid et al., 2018) 
 R GTCCATCTCACACCACCGGA 
Fibrobacter succinogenes F GCGGGTAGCAAACAGGATTAGA (Abdelmegeid et al., 2018) 
 R CCCCCGGACACCCAGTAT 
Megaspheara elsdenii F AGATGGGGACAACAGCTGGA (Abdelmegeid et al., 2018) 
 R CGAAAGCTCCGAAGAGCCT 
Prevotella albensis F GCGCCACTGACGCTGAAG (Khafipour et al., 2009) 
 R CCCCAAATCCAAAAGGACTCAG 
Prevotella brevis F GGTTTCCTTGAGTGTATTCGACGTC (Stevenson and Weimer, 
2007)  R CTTTCGCTTGGCCGCTG 
Prevotella bryantii F AGCGCAGGCCGTTTGG (Abdelmegeid et al., 2018) 
 R GCTTCCTGTGCACTCAAGTCTGAC 
Prevotella ruminicola F GAAAGTCGGATTAATGCTCTATGTTG (Stevenson and Weimer, 
2007)  R CATCCTATAGCGGTAAACCTTTGG 
Rumicoccus albus F ACGTCRTCCMCACCTTCCTC (Koike and Kobayashi, 2001) 
 R CCTCCTTGCGGTTAGAACA 
Rumicoccus flavefaciens F CGAACGGAGATAATTTGAGTTTACTTAGG (Denman and McSweeney, 
2006)  R CGGTCTCTGTATGTTATGAGGTATTACC 
Ruminobacter amylophilus F CTGGGGAGCTGCCTGAATG (Stevenson and Weimer, 
2007)  R GCATCTGAATGCGACTGGTTG 
Selenomonas ruminantium F CAATAAGCATTCCGCCTGGG (Abdelmegeid et al., 2018) 
 R TTCACTCAATGTCAAGCCCTGG 
Succinimonas amylolytica F CGTTGGGCGGTCATTTGAAAC (Abdelmegeid et al., 2018) 
 R CCTGAGCGTCAGTTACTATCCAGA 
Succinivibrio dextrinosolvens F TAGGAGCTTGTGCGATAGTATGG (Abdelmegeid et al., 2018) 
 R CTCACTATGTCAAGGTCAGGTAAGG 
Streptococcus bovis F TTCCTAGAGATAGGAAGTTTCTTCGG (Abdelmegeid et al., 2018) 
 R ATGATGGCAACTAACAATAGGGGT 
Treponema bryantii F AGTCGAGCGGTAAGATTG (Tajima et al., 2001) 
 R CAAAGCGTTTCTCTCACT 
Bacteria general 1  F GGATTAGATACCCTGGTAGT  (Abdelmegeid et al., 2018) 
 R CACGACACGAGCTGACG 
Bacteria general 2  F GTGSTGCAYGGYTGTCGTCA (Abdelmegeid et al., 2018) 
 R ACGTCRTCCMCACCTTCCTC 
aF: forward primer 






Table 2.3 - Effects of supplementing cows with a control diet (CON) or control diet plus 
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal 
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on BW, 
BCS, DMI, and energy balance. 
 
1Prepartum parameters were analyzed from -30 d to calving. 
2Postpartum parameters were analyzed from calving to 50 DIM. 
3Largest standard error of the mean. 






















Treatment  P-value 
CON YC SEM3 Diet Parity4 Time D x T5 
Prepartum1  
  BW, kg 773 785 16.4 0.61 <0.01   0.36 0.36 
  BCS         3.12         3.19     0.08 0.56 --   0.12 0.81 
  DMI, kg/day     12.2     12.7     0.61 0.59 -- <0.01 0.21 
  DMI, % BW        1.5       1.6     0.07 0.95 --   0.02 0.24 
  EB, Mcal/day         4.01         3.50     1.02 0.65   0.02   0.02 0.36 
Postpartum2 
  BW, kg 688 688 13.75 0.99 <0.01 <0.01 0.92 
  BCS          2.79         2.81   0.04 0.77 -- <0.01 0.28 
  DMI, kg/day      19.9     20.5   0.47 0.40 <0.01 <0.01 0.87 
  DMI, % BW        2.8       2.9   0.07 0.54 -- <0.01 0.97 
  EB, Mcal/day         -4.30        -5.93   1.26 0.23   0.27   0.17 0.98 
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Table 2.4 - Effects of supplementing cows with a control diet (CON) or control diet plus 
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal 
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on milk 
composition. 
Parameter 
Treatment  P-value 
CON YC SEM1 Diet Parity Time D × T2 
Milk yield, kg/d 34.3 36.8 1.15   0.13 <0.01 <0.01 0.78 
Milk composition 
  Milk fat, %     3.31     3.28 0.14   0.88 -- <0.01 0.59 
  Milk fat yield, kg/d     1.30     1.46 0.07   0.11 <0.01   0.19 0.97 
  Milk protein, %     3.18     3.14 0.05   0.52 -- <0.01 0.71 
  Milk protein yield, kg/d     1.06     1.12 0.03   0.26 <0.01 <0.01 0.95 
  Milk lactose, %     4.92     4.94 0.02   0.55 -- <0.01 0.58 
  SCC3     1.84     1.55 0.05 <0.01 <0.01   0.58 0.75 
  MUN, mg/dL   10.46   10.72 0.57   0.74 --   0.02 0.96 
ECM, kg/day 35.2 38.4 1.22   0.07 <0.01 <0.01 0.97 
Milk/DMI     1.90     1.95 0.05   0.52 -- <0.01 0.78 
ECM/DMI     1.89     1.99 0.05   0.18 --   0.03 0.96 
1Largest standard error of the mean 
2Interaction of treatment and days in milk 































Table 2.5 - Effects of supplementing cows with a control diet (CON) or control diet plus 
yeast culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal 
Health, Teaneck, NJ) in dairy cows during the peripartal period until 50DIM on VFA 
percentages. 
Parameter 
Treatment  P-value 
CON YC SEM1 Diet Parity Time D × T2 
pH   6.2   6.4 0.08 0.22 -- < 0.01 0.90 
NH3, mg/dL 10.4   9.9 0.78 0.68 <0.01   0.11 0.52 
Total VFA, nM 94.1 91.9 4.82 0.74 --   0.40 0.37 
VFA (mol/100 mol) 
  Acetate, % 64.6 64.7 0.84 0.93 -- <0.01 0.88 
  Propionate, % 24.3 24.1 0.77 0.85 -- <0.01 0.77 
  Butyrate, %   8.6   9.0 0.26 0.26   0.01   0.02 0.79 
  Isovalerate, %   1.5   1.4 0.04 0.02 -- <0.01 0.05 
  Valerate, %   0.9   1.0 0.04 0.24 <0.01 <0.01 0.04 
Acetate:Propionate   2.7   2.7 0.09 0.94 -- <0.01 0.92 
1Largest standard error of the mean. 





































Table 2.6 - Relative abundance (%) of target bacterial species mixed ruminal fluid from 
peripartal dairy cows supplemented with control diet (CON) or control diet plus yeast 
culture (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, 
Teaneck, NJ). 
Species2 
Treatment  P-value 
CON YC SEM1 Diet Time D × T3 
Anaerovibrio lipolytica 1.36 × 10-3 1.83 × 10-3 0.19 0.12 0.26 0.39 
Butyrivibrio fibrisolvens 8.53 × 10-4 9.92 × 10-4 0.15 0.32 0.27 0.87 
Butyvibrio proteoclasticus 1.28 × 10-1 1.28 × 10-1 0.15 0.98 0.37 0.48 
Eubacterium ruminantium 8.51 × 10-3 9.04 × 10-3 0.22 0.78 0.25 0.39 
Fibrobacter succinogenes 5.52 × 10-2 7.27 × 10-2 0.15 0.09 0.04 0.47 
Megaspheara elsdenii 3.65 × 10-4 5.53 × 10-4 0.22 0.05 <0.01 0.49 
Prevotella albensis 2.61 × 10-3 4.58 × 10-3 0.65 0.40 <0.01 0.01 
Prevotella brevis 8.74 × 10-2 7.12 × 10-2 0.04 <0.01 0.04 0.70 
Prevotella bryantii 2.96 × 10-2 2.30 × 10-2 0.58 0.66 <0.01 0.05 
Prevotella ruminicola 8.20 × 10-1 7.43 × 10-1 0.11 0.36 0.99 0.02 
Rumicoccus albus 2.59 × 10-3 2.59 × 10-3 0.23 0.99 0.19 0.98 
Rumicoccus flavefaciens 6.38 × 10-4 6.51 × 10-4 0.38 0.96 0.08 0.26 
Ruminobacter amylophilus 1.29 × 10-3 2.63 × 10-3 0.82 0.39 0.42 0.45 
Selenomonas ruminantium 2.32 × 10-1 2.39 × 10-1 0.10 0.73 0.04 0.11 
Succinimonas amylolytica 1.85 × 10-3 4.63 × 10-3 0.39 0.03 0.13 0.12 
Succinivibrio dextrinosolvens 5.22 × 10-3 6.78 × 10-3 0.53 0.63 0.66 0.05 
Streptococcus bovis 9.62 × 10-4 9.54 × 10-4 0.27 0.97 0.02 0.42 
Treponema bryantii 4.37 × 10-3 5.62 × 10-3 0.33 0.46 0.18 0.76 
1Largest standard error of the mean is shown. 
2Data were log-transformed before statistics. The standard errors of the means associated with log-transformed data are 
in log scale. 


















Table 2.7 - Effects of supplementing cows with a control diet (CON) or control diet plus 
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) in blood biomarkers related to muscle body mass, 
metabolism and oxidative stress in dairy cows during the peripartal period until 50DIM. 
Parameter 
Treatment   P-value 
CON YC SEM1 Diet Time D × T3 
Muscle body mass 
   Creatinine, µmol/L   88.1   89.6 1.04  0.30 < 0.01 0.56 
   Urea, mmol/L       4.60       4.58 0.14  0.92     0.19 0.39 
Metabolism 
   Glucose, mmol/L       4.24       4.24 0.05  0.98 < 0.01 0.84 
   NEFA, mmol/L2       0.31       0.25 0.12  0.10 < 0.01 0.02 
   BHB, mmol/L2       0.43       0.42 0.06  0.83 < 0.01 0.13 
Oxidative stress        
   ROM, mg H2O2/100 mL   14.0   15.0 0.52  0.19    0.03 0.40 
   FRAP, µmol/L2 142.0 136.3 0.04  0.28 < 0.01 0.48 
1Largest standard error of the mean is shown. 
2Data were log-transformed before statistics. The standard errors of the means associated with log-transformed data are 
in log scale. 




Figure 2.1 - Milk yield (A), SCC (B), ECM (C) and ECM/DMI (D) in cows 
supplemented with a control diet (CON) or control diet plus yeast culture (YC; Cellerate 
Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, NJ) in dairy 
cows during the transition period until 50DIM. Values are means and the standard errors 
are represented by vertical bars. 
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Figure 2.2 - Effects of control diet (CON) or control diet plus a yeast culture supplement 
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, 
NJ) on ruminal valerate and isovalerate in dairy cows during the transition period until 












Figure 2.3 - Effects of control diet (CON) or control diet plus a yeast culture supplement 
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, 
NJ) on relative abundance (%) of microbial species in rumen fluid in dairy cows during 
the peripartal period until 50DIM. Values are means and the standard errors are 






Figure 2.4 - Effects of control diet (CON) or control diet plus a yeast culture supplement 
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, 
NJ) on relative abundance (%) of microbial species in rumen fluid in dairy cows during 
the peripartal period until 50DIM. Values are means and the standard errors are 














Figure 2.5 - Effects of control diet (CON) or control diet plus a yeast culture supplement 
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, 
NJ) on blood NEFA (A) and BHB (B) in dairy cows during the transition period until 




























































Diet, P = 0.10
Time, P <0.01
Diet x Time, P = 0.02
Diet, P = 0.83
Time, P <0.01







CHAPTER 3. YEAST CULTURE SUPPLEMENTATION EFFECTS ON 
SYSTEMIC AND POLYMORPHONUCLEAR LEUKOCYTES MRNA 
BIOMARKERS OF INFLAMMATION AND LIVER FUNCTION IN 
PERIPARTAL DAIRY COWS. 
 
ABSTRACT 
 Feeding yeast culture additives has been attributed to health benefits during the 
transition period of dairy cows. The objective of this study was to evaluate the effects of 
feeding a commercial yeast culture on blood biomarkers of inflammation and liver 
function, and gene expression in polymorphonuclear leukocytes (PMNL) in dairy cows 
during the transition period until 50 d postpartum. Forty Holstein dairy cows were used in 
a randomized complete block design from -30 to 50 d and blocked according to parity, 
previous lactation milk yield, and genetic merit. At -30 d, cows were assigned to a basal 
diet plus a top-dressed of either 114 g/d of ground corn (CON; n = 20) or 100 g/d of 
ground corn and 14 g/d yeast culture product (YC; n = 20; Cellerate Culture Classic HD; 
Phibro Animal Health, Teaneck, NJ). Cows received the same close-up diet from -30 to 
calving (0.63 Mcal/kg DM and 12.3% CP) and lactation diet after calving (0.73 Mcal/kg 
DM and 15.6% CP). Blood samples were collected at -30, -15, 7, 14, and 30 DIM to 
evaluate liver function and inflammation biomarkers. Blood samples for PMNL gene 
expression were collected at -30, -15, 5, 10, and 30 d. The mRNA in PMNL was analyzed 
for genes associated with inflammation, cellular receptor, and oxidative stress. A trend for a 
Diet × Time interaction was observed in GGT, where greater GGT was observed in YC 
than CON cows at 30 d. Negative acute-phase proteins (APP), albumin, and paraoxonase 
tended to be lower in YC than CON cows, while the positive APP, haptoglobin, tended to 
be higher in YC than CON. In PMNL mRNA expression, the NFKB1 was upregulated in 
68 
 
YC cows in comparison to CON. A trend for upregulation of TNFA, IL10, SELL, and 
TLR2 was observed in cows supplemented with YC.  The present study showed that yeast 
culture supplementation might stimulate a mild inflammatory response in transition dairy 
cows, based on blood biomarker and PMNL mRNA gene expression. 
Key words: transition period,  inflammation, yeast culture 
 
INTRODUCTION 
In dairy cows, the transition period is defined as 3 weeks before through 3 weeks 
after parturition (Drackley, 1999), and it is the most critical period during the cow’s life. 
The metabolic stress and altered immune function may contribute to the noticeable 
incidence of health disorders in early lactation in dairy cows (Goff and Horst, 1997). The 
development of nutritional-based strategies that can modulate an immune response will 
positively affect dairy cows’ health. Yeast-based products have been used in livestock for 
many years due to the beneficial effects on animals, with the most common species being 
S. cerevisiae.  
During the transition period, yeast-based products have been shown to improve 
DMI (Dann et al., 2000; Shi et al., 2019) and milk yield (Nocek et al., 2011; Zaworski et 
al., 2014), while others did not observe the same effects (Olagaray et al., 2019; Stefenoni 
et al., 2020). Recent findings also suggest that yeast may influence immune function. 
However, the mechanism behind the interaction between supplemented yeast and innate 
immunity still unclear. According to Lopreiato et al. (2020), the responses can be 
attributed to a better energy status promoted by positive effects on digestive function or 
activation of the immune system by sensing yeast components. 
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Jensen et al. (2008) demonstrate that yeast culture provides antioxidant, anti-
inflammatory, and immuno-modulatory activities in vitro. Yuan et al. (2015b) reported 
that yeast culture plus enzymatically hydrolyzed yeast could enhance humoral and 
mucosal immunity and modulated uterine inflammatory signals and mammary gland 
health in transition dairy cows. Recently, Knoblock et al. (2019) evaluated the effects of 
S. cerevisiae fermentation product in dairy cows fed diets with different starch content 
during the early lactation and observed that yeast supplementation coupled with low-
starch diets might reduce inflammation. In lactating dairy cows, yeast cell wall 
supplementation increased mRNA expression of cytokines in peripheral blood 
mononuclear cells, which underscores yeast’s ability to mediate immune function (Aung 
et al., 2020).  
The objective of this study was to assess the effects of yeast-based products on 
metabolism, inflammation, liver function, and immune function through blood 
biomarkers and gene expression in PMNL in dairy cows during the transition period until 
50 DIM. 
 
MATERIAL AND METHODS 
Animals, Experimental Design and Dietary Treatments 
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota 
State University approved all the procedures for this study. Forty Holstein dairy cows 
were used in a randomized complete block design and were blocked according to 
lactation, calving date, and previous lactation milk yield. There were 6 primiparous and 
34 multiparous enrolled in this study. Cows received the same close-up diet (1.32 Mcal of 
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NEL/kg and 14.15% CP) 7 d prior to starting dietary treatments as an adaptation period. 
Then, at -30 d before expected calving, cows were assigned to the treatments. The 
treatments were top-dressed a control (CON; 114g/h/d ground corn; n = 20) or CON plus 
yeast culture product (YC; 100g ground corn + 14g YC/h/d; n = 20). After parturition, all 
cows were fed the lactation basal diet (1.72 Mcal of NEL/kg and 16.05% CP) as a total 
mixed ration, and the supplementation continued through 50d postpartum.   
The cows were enrolled in the experiment from mid-September 2018 to early 
April 2019. Cows were feed using an individual gate system (American Calan, 
Northwood, NH), and the intake of dry matter (DM) was recorded daily. Diets were 
formulated using the NDS professional (Nutrition Dynamic System; RUMN Sas) to 
meet the requirements of the average cow in the group according to the NRC (2001) 
(Table 2.1). Dry matter of individual feed ingredients was determined weekly 
accordingly, and diets were adjusted accordingly to maintain formulated DM ratios of 
ingredients in the TMR. Cows were fed once daily at 0500 h before morning milking, and 
feed offered was adjusted daily to achieve 5 to 10% refusals. 
During the close-up period, the cows were housed in a bedded pack pen, and three 
days before the expected calving date, the cows were reallocated in individual pens 
bedded with straw until parturition. On day 3, after calving, cows were moved to a 
lactation free-stall barn where they were receiving the same lactation basal diet until 50 
DIM. Body weight was measured weekly for each cow at the same time in the afternoon. 
Body condition score (BCS) (scale 1= thin to 5= obese) was assigned by two individuals, 
and the average score was used for statistical analysis. 
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Blood Collection and Analyses 
Blood was sampled from the coccygeal vein before morning feeding using a 20-
gauge BD Vacutainer needle (Becton Dickinson, Franklin Lakes, NJ) at -30, -15, 7, 14, 
and 30 d relative to parturition from a subset of cows (n=8 cows/treatment). Blood was 
collected into Vacutainer (5 mL, BD Vacutainer, Becton Dickinson, Franklin Lakes, NJ) 
containing either serum clot activator or lithium heparin. After collection, tubes 
containing lithium heparin were placed on ice, and tubes with serum clot activator were 
kept at 21°C until centrifugation. Serum and plasm were obtained by centrifugation at 
1,300 × g for 15 min at 21°C and 4°C, respectively. The aliquots of plasma were frozen 
at -80°C until further analysis.  
Samples were analyzed for biomarkers of liver function [e.g., total bilirubin, 
aspartate aminotransferase (AST/GOT), γ-glutamyl transpeptidase (GGT), cholesterol 
and paraoxonase (PON)], inflammation [e.g., albumin, ceruloplasmin, haptoglobin and 
interleukin 1β (IL-1β)], using kits purchased from Instrumentation Laboratory 
(Lexington, MA) and the procedures were described by (Trevisi et al., 2012; Batistel et 
al., 2016; Jacometo et al., 2016). 
PMNL Isolation  
Neutrophils were isolated based on procedures described by Osorio et al. (2013b). 
Briefly, blood (~100 mL) was collected into evacuated tubes (8 mL, BD Vacutainer, 
Becton Dickinson, Franklin Lakes, NJ) containing solution A of trisodium citrate citric 
acid and dextrose (ACD)  from the coccygeal vein prior to morning feeding at -30, 5, 15, 
and 30 days relative to parturition from a subset of cows (n=8 cows/treatment). Tubes 
were mixed by inversion immediately after collection and placed on ice (~4 °C) until 
72 
 
isolation.  Samples were centrifuged at 600 × g for 30 min at 4 °C. The plasma, buffy 
coat, and approximately one-third of the red blood cells were discarded. The remaining 
sample was poured into a 50-mL conical tube (Fisher Scientific, Pittsburgh, PA). Red 
blood cells (RBC) were lysed with twenty-five milliliters of deionized water at 4 °C was 
added into the tube, followed by the addition of 5 mL of 5 × PBS at 4 °C to restore an 
iso-osmotic environment. Samples were centrifuged at 900 × g for 10 min at 4°C, and the 
supernatants were decanted. The cell pellet was washed with 10 mL of 1 × PBS, and the 
cell suspension was centrifuged at 900 × g for 5 min at 4°C, and the supernatants were 
decanted. The remaining RBC were lysed with 8 mL of ice-cold deionized water, 
homogenized gently by inversion and 2 mL of 5 × PBS at 4°C was added. The samples 
were centrifuged at 900 × g for 5 min at 4°C, and the supernatant was discarded. 
Subsequently, samples were washed twice using 10 mL of 1 × PBS at 4°C were 
performed, followed by centrifugation 900 × g for 5 min at 4°C. The PMNL pellet was 
homogenized with 1.5 mL of 1 × PBS at 4°C, transferred to a 2-mL RNase-DNase-free 
microcentrifuge tube and centrifuged at 6,000 × g (Sorvall Legend Microcentrifuge 21R) 
for 5 min at 4°C. The final PMNL pellet was homogenized in 1 mL of Trizol reagent 
(Invitrogen, Carlsbad, CA) and stored at -80°C until further gene expression analysis.  
RNA Isolation, cDNA Synthesis, and Real-Time Quantitative PCR 
Total RNA was extracted from blood PMNL using Trizol (Invitrogen, Carlsbad, 
CA) reagent in combination with the RNeasy® Plus Mini Kit (Qiagen, Hilden, 
Germany), following the manufacturer’s instructions with some modifications. Briefly, 
the cell pellet immersed in Trizol was transferred to a 2-mL RNase-free O-ring tube, 
containing one stainless steel bead, 5 mm (Qiagen, Hilden, Germany) and homogenized 
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in a Beadbeater (BioSpec Products, Bartlesville, OK) for 1 min. After homogenization, 
the lysate was transferred to a 2-mL RNase-free microtube and 200 µL of 
Phenol:chloroform (Invitrogen, Carlsbad, CA) at 4 °C was added in order to isolate the 
RNA from the organic phase. After centrifugation at 13,000 × g for 15 min at 4 °C, the 
upper phase supernatant was transferred into a new 2-mL RNase-free microtube. The 
total RNA was purified using RNeasy® Plus Mini Kit and eluted in 50 µL of RNase-free 
water. The RNA quantity for all PMNL samples was 327.17 ± 292.99 ng/µL and purity 
(260/280) was 2.02 ± 0.10 determined using NanoDrop spectrophotometer (ND 1000, 
NanoDrop Technologies Inc., Wilmington, DE).  
RNA isolated from neutrophils was used for qPCR analysis. Complementary 
DNA (cDNA) synthesis was performed according to Osorio et al. (2013a) with 
modifications. cDNA was synthesized using 100 ng RNA, 1 µL random primers 
(Invitrogen Corp., CA), and 9 µL DNase/RNase free water (HyClone, UltraPure™). The 
mixture was incubated at 65 °C for 5 min and kept on ice for 5 min. A total of 9 µL of 
master mix composed of 4 µL 5X Reaction Buffer, 1 µg dT18 (Operon Biotechnologies, 
AL), 2 µL 10 mmol/L dNTP mix (Invitrogen Corp., CA), 0.25 µL (50 U) of 
RevertAidTM Reverse Transcriptase (Fermentas Inc., MD), 0.125 µL of RNase Inhibitor 
(10 U, Promega, WI), and 1.625 µL of DNase/RNase free water (HyClone, UltraPure™) 
was added. The reaction was performed in an Eppendorf Mastercycler® Gradient using 
the following temperature program: 25 °C for 5 min, 42 °C for 120 min and 70 °C for 5 
min.  
The cDNA was diluted 1:4 with RNase-free water (HyClone, UltraPure™). The 
quantitative PCR was performed in a MicroAmp Optical 384-Well Reaction Plate 
74 
 
(Applied Biosystems, Grand Island, NY). In each well, 4µL diluted cDNA combined 
with 6 µL of a mixture composed of 5 µL 1 × SYBR Green master mix (Applied 
Biosystems, CA), 0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL 
DNase/RNase free water (HyClone, UltraPure™). Samples were run in triplicate, and a 
6-point relative standard curve plus a non-template control were used. The reaction was 
performed in QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems, 
Walthan, MA) following the conditions: 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s 
at 95°C (denaturation) and 1 min at 60°C (annealing + extension). A dissociation curve 
was performed (gradient from 95°C to 60°C to 95°C for 15s) to check the amplicon 
quality.   
Primers sequence information and sources can be found in Table 3.1. In this 
study, the genes Golgin A5 (GOLGA5), Oxysterol Binding Protein Like 2 (OSBPL2), and 
Single-Strand-Selective Monofunctional Uracil-DNA Glycosylase 1 (SMUG1) were used 
as internal control genes (ICGs) as described by Moyes et al. (2010). The final gene 
expression data were normalized with the geometric mean of the 3 internal control genes. 
The stability of the ICG was assessed using the geNorm software (Vandesompele et al., 
2002) with a favorable final pairwise variation of 0.17.  
Target genes measured are described in  Table 3.2, and these were related to 
inflammation [tumor necrosis factor alpha (TNFA), nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 1 (NFKB1), interleukin 1B (IL1B) and interleukin 
10 (IL10), interleukin 6 (IL6)] and cell receptors [toll like receptor 2 (TLR2), toll-like 





Blood biomarkers and gene expression data were analyzed using the MIXED 
procedure of SAS 9.4 (SAS Institute Inc., Cary, NC) using diet, time (day or week), and 
their interactions as fixed effects and cow nested within treatment as a random effect. 
Parity effect was removed from the model any time it was nonsignificant (P > 0.05). 
The exponential correlation covariance structure SP for repeated measures was 
used for the analysis of gene expression and blood biomarkers data with the following 
model: 
𝑦𝑖𝑗𝑘 =  𝜇 + 𝐷𝑖 + 𝑇𝑗 + 𝐷𝑇𝑖𝑗 + 𝛼𝑘 +  𝑒𝑖𝑗𝑘  
where yijk is the dependent, continuous variable; μ is the general mean; Di is the fixed 
effect of the diet (i =1 or 2, namely, CON or YC); Tj is the fixed effect of the time (j = 1, 
2, 3 or 4, namely, -30, 5, 15, and 30 DIM); DTij is the fixed effect of ith treatment by jth 
time of the interaction.; αk is the random effect of cow; eijk  is the random residual.  
Blood metabolites data were log-scale transformed if needed to comply with 
normal distribution of residuals and subsequently back-transformed. Gene expression 
data were log-transformed prior to statistical analysis. Data on day -30 was used as a 
covariate for all the analyses. The covariate of previous 305-d milk yield was maintained 
in the model for all variables for which it was significant (P < 0.05). Statistical 




Blood Biomarkers  
Main effects of diet, time, and their interactions for blood metabolites associated 
with liver function and inflammation are presented in Table 3.3 and Figure 3.1. There 
was a trend (P= 0.07) for a D × T in GGT, which resulted in greater concentrations of 
GGT in YC fed cows than CON at 30 DIM (P < 0.01), and this effect was reflected in an 
overall greater (P = 0.03) GGT in YC cows. Similar to GGT, haptoglobin tended (P = 
0.12) to be greater in YC cows in comparison to CON. In contrast to GGT and 
haptoglobin, there was a trend for lower PON (P = 0.12) and albumin (P = 0.06) in YC 
fed cows when compared to CON. Total bilirubin, GOT, cholesterol, ceruloplasmin and 
IL-1β were not affected by diet, time, or their interactions. 
Gene Expression 
Main effects of diet, time, and their interactions for PMNL mRNA gene 
expression are present in Table 3.4 and Figure 3.2. There was a trend (P = 0.11) for an 
upregulation of TNFA in YC cows than CON cows. The mRNA expression of NFKB1 
was greater (P = 0.04) in YC than CON cows. Similar to TNFA, there was a tendency for 
greater (P = 0.07) mRNA expression of IL10 in cows supplemented with YC than CON 
(Figure 3.2). There was a trend (P = 0.11) for an upregulation of SELL in YC fed cows in 
comparison to CON (Figure 3.2). Similar to SELL, there was a trend (P = 0.14) for a 
greater expression of TRL2 in YC than CON group. The expression of IL1B, TLR4, and 




Effects on performance parameters, blood biomarkers (i.e., muscle body mass, 
metabolism, and oxidative stress) and rumen fermentation and bacteria populations for 
this study have been evaluated in a companion manuscript. In summary, we observed a 
trend for a diet effect in milk yield, where YC cows (36.8 ± 1.15 kg/d) produced 2.5 kg/d 
more milk than CON cows (34.3 ± 1.15 kg/d). The latter was reflected in a trend for 
greater energy corrected milk (ECM) and milk fat yield in YC cows than CON. Yeast 
culture supplementation also promoted alterations in rumen fermentation, increasing 
valerate by optimizing the abundance of cellulolytic and lactate-utilizing bacteria. The 
current companion manuscript focused on systemic and PMNL mRNA indicators of 
inflammation and liver function during the transition period of dairy cows supplemented 
with a yeast culture.  
Inflammation 
During the transition period, dairy cows are more susceptible to health disorders 
such as mastitis, ketosis, retained placenta, metritis, and displaced abomasum. A common 
factor associated with the development of these disorders is the immune dysfunction 
(Sordillo, 2016), which, in turn, is caused by metabolic changes during the transition 
period.   
Inflammation is a component of the immune response that involves physiological 
and pathological responses that helps the body adapt or eliminate an adverse stimulus to 
return tissues to normal function or homeostasis (Bradford et al., 2015; Sordillo, 2016). 
The most common event to occur during the inflammation is a systemic or acute phase 
response (APR). The primary stimulators of the APR are the pro-inflammatory cytokines, 
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including TNFα, IL1β, and IL6 (Gauldie et al., 1987). These cytokines can activate 
leukocytes and endothelial cells (Bannerman et al., 2009) and alter the normal protein 
synthesis in hepatocytes. These proteins for which their hepatic synthesis is altered 
during APR are called acute phase proteins (APP). According to Ceciliani et al. (2012), 
during the acute phase response, the concentration of APP change dramatically, and 
because of this, they were classified as positive (increase) or negative (decrease) APP. 
The most common positive APP are serum amyloid A, haptoglobin, and ceruloplasmin, 
and the negative APP include albumin, PON, and apolipoproteins. 
During the transition period, alterations in APP have been used to monitor 
inflammation and liver function (Trevisi et al., 2010). In a retrospective analysis, Bertoni 
et al. (2008) classified early lactation dairy cows according to a liver activity index (LAI) 
and evaluated APP concentrations based on this classification. The albumin levels from 
cows classified as a high LAI was 34.5 g/L, while low LAI cows had 29.0 g/L. In the 
current study, albumin reached nadir levels at 7 DIM, regardless of treatment, at which 
point the albumin levels in YC and CON cows were 34.4 and 35.6 g/L, respectively. 
These data indicate that while YC cows tended (P = 0.06) have lower albumin 
concentration than CON, this was comparable to that in cows classified with a high LAI 
in Bertoni et al. (2008). The levels of albumin are constant during the pregnancy (35-36 
g/L) followed by a reduction soon after calving and returning to prepartal levels (36-37 
g/L) as cows progress into their lactation (Bertoni and Trevisi, 2013). The same effect 
was observed in our study. The latter suggests that it is less likely that YC cows were 
under a significant inflammation level, and perhaps the impact on liver function was 
minimal.   
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 The positive APP, haptoglobin, has been observed to increase during stress 
periods promoting an APR; therefore, low LAI cows have been observed to have greater 
haptoglobin than high LAI cows (Bertoni et al., 2008). The trend for overall greater 
haptoglobin in YC cows than CON seems to be driven by the greater haptoglobin in YC 
cows at 7 and 14 DIM (Figure 3.1). However, the maximal haptoglobin ca. 0.32 g/L in 
YC cows at 7 DIM reached similar levels than cows classified as high LAI (0.3 g/L) at 7 
DIM (Bertoni et al., 2008). After 7 DIM, YC cows presented an evident decline in 
haptoglobin, similar to that observed in Bertoni et al. (2008). Maximal haptoglobin 
commonly occurs within the first week postpartum. For instance, at 7 DIM, a ~0.8 g/L 
haptoglobin concentrations have been reported (Bertoni and Trevisi, 2013). Our data 
suggest that YC cows experienced a mild activation of the immune system that was 
transient as this group of cows did not present common inflammation patterns of low 
albumin coupled with high haptoglobin. In contrast to our results, yeast supplementation 
tended to reduce haptoglobin levels in different conditions (Dias et al., 2018; Perdomo et 
al., 2020). For instance, under heat stress, early lactation dairy cows supplemented with 
up to 1g the dose of live yeast tended to reduce haptoglobin (Perdomo et al., 2020). Dias 
et al. (2018) evaluated the effects of a culture of S. cerevisiae in lactating dairy cows fed 
diets with varying starch content. The supplementation of yeast culture attenuated the 
inflammatory stimulus, tended to reduce the concentration of haptoglobin in high-starch 
diets. The authors further discussed that yeast can minimized the risk of cows developing 
subacute ruminal acidosis and systemic inflammation because of the translocation of 
inflammatory mediators from rumen to blood. However, the yeast effect attenuating 
inflammation can be due the conditions that the lactating dairy cows were subjected to, 
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like heat stress or high-starch diets. In transition cows, due to the metabolic changes 
associated to NEB, the haptoglobin levels can vary more, especially post-calving.   
Liver Function 
The low levels of PON during the early postpartum period in dairy cows have 
been associated with metabolic disorders such as excessive fat mobilization and 
triglyceride accumulation (Turk et al., 2004). Bionaz et al. (2007) performed a 
retrospective analysis by classifying cows based on their blood PON concentration with 
the aim to test the feasibility of using this metabolite as a marker for liver function. The 
overall PON values for cows classified as high PON activity group were 92 U/mL, and 
PON concentration increased significantly in this group during the first 2wk of lactation. 
In our study, the PON levels for YC (95.0 U/mL) and CON (102.5 U/mL) cows were 
greater than those reported by Bionaz et al. (2007), followed by an increase postpartum. 
Similar to albumin, the lowest PON levels in YC cows were observed at 7 DIM (Figure  
3.1); however, this PON level in YC cows was similar to that in cows designated as high 
PON activity group in Bionaz et al. (2007). Our results suggest that both YC and CON 
cows were at a greater level of PON, indicating that cows were not in an inflammatory 
condition. During inflammatory conditions, negative APP, such as PON, albumin, 
lipoproteins and retinol-binding protein, typically decrease (Bionaz and Loor, 2007; 
Trevisi et al., 2012). The reduction of PON observed at 7 DIM in YC cows can happen in 
transition dairy cows due to a reduction in liver-derived HDL, which plays an important 
role in PON’s availability in circulation, particularly before calving (Bionaz et al., 2007). 
Our study is limited in that we cannot ascribe the observed effect in liver-derived HDL 
because we did not measure this metabolite.  
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The GGT is a membrane-associated enzyme involved in hepatic AA metabolism, 
and its plasma concentration has been associated with liver cell damage (Bionaz et al., 
2007). In the current study, we observed an increase in GGT in YC cows, and this effect 
was more pronounced at 30 DIM, where GGT levels for YC cows were 94.9 U/L. Bertoni 
et al. (2008) showed that GGT levels were not different across different LAI-based 
groups, suggesting that LAI does not account for liver cell damage. According to Trevisi 
et al., (2001), impaired liver function is not equal to lower liver activity due to liver 
damaged, but rather a diverted synthesis of proteins (i.e., APP) during inflammation. 
Although we can conclude that YC cows had greater GGT than CON by 30 DIM, these 
levels did not surpass those observed in Bertoni et al. (2008), which indicates that YC 
cows in the current study were less prone to develop liver cell damage. Our results are 
also in agreement with others, where transition dairy cows presented high concentrations 
of GGT at 30DIM (Rodriguez-Jimenez et al., 2018; Mezzetti et al., 2019). Other authors 
have reported the effects of yeast supplementation in GGT levels in dairy cows (Al 
Ibrahim et al., 2010; Aung et al., 2019). In lactating dairy cows, yeast cell wall 
supplementation did not affect the GGT concentration, but the levels (27.38 U/L) were 
higher than those observed in our study  (Aung et al., 2019). Live yeast supplementation 
did not affect the GGT levels in early lactating dairy cows; however, the concentration 
(10.36 U/L) was lower than we observed in this study (Al Ibrahim et al., 2010). Taken 
together, our results suggest that YC cows were in a mild inflammatory condition, 




The immune system relies on the innate immune system components to detect and 
mount an early response to infectious microorganisms. In the cell surface of immune 
cells, there are receptors known as pattern recognition receptors that recognize two 
classes of molecules: pathogen-associated molecular patterns, associated with pathogens 
products, and damage-associated molecular patterns, which are related to components of 
host's cells that are released during cell damage or death (Sordillo, 2016). When 
activated, these receptors initiate a signal transduction pathway that results in gene 
transcription and activation of pro-inflammatory cytokines, playing an important role in 
triggering and regulating the immune responses (Lee and Hwang, 2006).  
The antioxidant, anti-inflammatory, and immunomodulatory properties of yeast 
culture have been demonstrated in vitro. Such characteristics can mediate interactions 
between different immune cell populations, including neutrophils, monocytes, dendritic 
cells, B cells, T cells, and natural killer cells (Jensen et al., 2008). In the same study, 
Jensen et al. (2008) indicated that the mode of action of yeast culture remains unknown; 
however, this could be partially supported by an initial cellular interaction in gut mucosal 
tissue, resulting in changes in blood metabolites and cytokine profile. In our study, we 
observed that yeast culture altered blood biomarkers related to inflammation and liver 
function, and gene expression in PMNL, suggesting a cellular interaction between 
immune cells and yeast.   
The immunomodulatory effects of yeast have been reported on genes related to 
inflammation across different species (Zanello et al., 2011; Yuan et al., 2015b; Adeyemi 
et al., 2019). Zanello et al. (2011) showed that S. cerevisiae (strain CNCM I-3856) exerts 
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an immunomodulatory effect in porcine intestinal epithelial cells, activating genes related 
to inflammation. In weaning pigs supplemented with S. cerevisiae fermentation products, 
Weedman et al. (2011) reported an upregulation of TLR2 and TLR4 in mesenteric lymph 
nodes on 1 d after weaning, suggesting that yeast culture had primed immune cells for the 
changes that occur during the weaning period. In transition dairy cows, Yuan et al. 
(2015b) reported that yeast culture plus enzymatically hydrolyzed yeast magnified 
humoral and mucosal immunity, causing an overall improvement in uterine and 
mammary gland health. In newly weaned beef steers, supplementation with S. cerevisiae-
based product was attributed with upregulating gene networks responsible for promoting 
the animal’s immune response to pathogens (Adeyemi et al., 2019). 
To the best of our knowledge, there are no published data evaluating gene 
expression in bovine PMNL responsiveness of yeast culture supplementation. In the 
current study, we observed that NFKB1, TNFA, and TLR2 were upregulated to a lesser 
extent. The NFKB1 is a transcription factor associated with inflammation. An 
inflammatory response commonly causes an upregulation of NFKB1, which, in turn, 
upregulates cytokines such as TNFA and IL10, as well as several other genes related to 
inflammation (Trevisi et al., 2011; Moyes et al., 2014). The upregulation of NFKB1 in 
cows supplemented with YC can be associated with increased blood biomarkers related 
to inflammation and liver function, previously discussed. The effects on blood 
metabolites indicating mild inflammatory condition in YC cows could be reflected in the 
upregulation of NFKB1 and, consequently, activation of other cytokines. Due to S. 
cerevisiae-based supplementation, Adeyemi et al. (2019) observed an upregulation of 
genes involved in the immune response, such as TNFA and TLR2 detected in whole-blood 
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RNA gene expression. In mice, yeast cell wall supplementation induced a release of 
proinflammatory cytokines, such as TNFA (Walachowski et al., 2016), similar to our 
findings. 
 Neutrophils are targeted by IL-10, a cytokine commonly associated with the 
resolution of the inflammation (Moore et al., 2001; Bazzoni et al., 2010). This cytokine 
expression has been reported in transition dairy cows in different conditions (Zhou et al., 
2015; Batistel et al., 2017). Transition dairy cows fed with a prepartal high-energy diet 
upregulated the anti-inflammatory IL10 in PMNL, and such upregulation was found at 
−14 and 7 DIM (Zhou et al., 2015). In our study, an upregulation of proinflammatory 
cytokines was observed in YC cows, coupled with the upregulation of IL10. The 
production of proinflammatory cytokines is inhibited by IL-10, which helps to limit the 
duration and pathology of inflammatory responses (Moore et al., 2001). Yeast improving 
the production of anti-inflammatory cytokines in transition dairy cows may indicate a 
pivotal effect of this feed supplement by activating the immune response aiding on the 
resolution of inflammation since cows experience an immune dysfunction during this 
period. The alterations of immunity in transition dairy cows, mainly after parturition, can 
be exacerbated by metabolic disorders (Sordillo, 2016).  
In a recent study, Aung et al. (2020) isolated peripheral blood mononuclear cells 
from lactating dairy cows supplemented with yeast cell wall and observed that 
supplementation increased the leukocyte population and upregulated IL8 and IL12 in 
mononuclear cells, which might enhance the cellular immune function. The actual 
mechanism that yeast uses to stimulate an inflammatory response in ruminants still 
unclear, but the yeast cell wall fraction, medium used to grow the yeast, and yeast species 
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will likely play a fundamental role in this mechanism. In non-ruminants, β-glucan 
fragments present in the yeast cell wall have been suggested to stimulate the immune 
system (Alugongo et al., 2017). The Dectin-1 pathway is the most studied initial 
interaction of dietary β-glucans with the immune system, and the signaling cascade 
results in upregulation of TNFA and interleukins (e.g., IL-2, IL-10, IL-12, and IL-4), as 
well as the production of reactive oxygen species (ROS) (Willcocks et al., 2006). We did 
not evaluate the Dectin-1 pathway in our study; however, it would be interesting looking 
at this pathway in further studies. 
The SELL gene encodes the L-selectin protein expressed in the cell surface of 
PMNL that mediates its initial attachment to inflammation sites in the endothelium 
(Paape et al., 2003). The L-selectin facilitates the interaction between leukocytes and 
endothelial cells to start the process called “rolling” (Raffler et al., 2005). After rolling, 
the PMNL binds to additional endothelial receptors such as intercellular adhesion 
molecule (ICAM), making tighter attachments between PMNL and endothelium. In the 
current study, we observed a trend for an upregulation of SELL in YC cows, meaning that 
the neutrophils might be stimulated due to yeast culture supplementation.  
Based on gene expression results, it is plausible that yeast culture supplementation 
elicits an immune response in transition dairy cows. This is based on PMNL in YC cows 
being more stimulated than CON, suggesting that YC cows were exposed to an 
inflammatory stimulus. We can assume that yeast cell wall fragments such as β-glucans 
can bypass ruminal fermentation and promote PMNL gene expression alterations in the 
lower gastrointestinal tract. The exact mechanism that yeast may use to escape ruminal 
fermentation and interact with immune cells still inconclusive. We can also speculate that 
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β-glucans fragments can interact with membrane receptors in the ruminal epithelium, 
promoting the recruitment of immune cells and, in consequence, an immune response.   
 
CONCLUSIONS 
Supplementation of yeast culture derived from S. cerevisiae has been examined 
for many years to improve performance and health in dairy cows. In transition dairy 
cows, it is well known that the immune system is compromised, and this type of 
supplementation can be helpful during this challenging period. The present study showed 
that yeast supplementation might stimulate a mild inflammatory response in transition 
dairy cows, based on blood biomarker and PMNL mRNA expression. This can be 
associated with a natural response to yeast cell wall components, such as β-glucans, that 
can activate the immune system. In a companion paper, we reported the effects of yeast 
supplementation on performance, and we conclude that mild inflammatory conditions in 
YC did not cause a negative effect on DMI and milk yield. This result confirms that yeast 
culture could stimulate the immune system in transition dairy cows and promote a 
pronounced immune response against pathogen infection.   
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Table 3.1 - GenBank accession number, hybridization position, sequence and amplicon 
size of primers for Bos taurus used to analyze gene expression by qPCR. 
Accession no. Symbol Primers Primers (5’-3’) Amplicon size 
(bp) 
EU276074.1 IL10 F.171 GAAGGACCAACTGCACAGCTT  98 
  R.268 AAAACTGGATCATTTCCGACAAG  
NM_174093.1 IL1B F.453 TCCACCTCCTCTCACAGGAAA 100 
  R.552 TACCCAAGGCCACAGGAA  
NM_001040555.1 IRAK1 F.950 CCTCAGCGACTGGACATCCT 103 
  R.1052 GGACGTTGGAACTCTTGACATCT  
NM_001076409.1 NFKB1 F.172  TCAACCGGAGATGCCACTAC 95 
  R.266 ACACACGTAACGGAAACGAAATC  
NM_174182.1 SELL F.588  CTCTGCTACACAGCTTCTTGTAAACC 104 
  R.691 CCGTAGTACCCCAAATCACAGTT  
NM_174197.2 TLR2 F.1201  AAGAGTCACAATAGAAAG 102 
  R.1302 GCTATTTATGACACATCCAA  
NM_174198.6 TLR4 F.102  GCTGTTTGACCAGTCTGATTGC  102 
  R.203 GGGCTGAAGTAACAACAAGAGGAA  
EU276079.1 TNFα F.438 TCTCAAGCCTCAAGTAACAAGCC 100 




















Table 3.2 - Genes selected for transcript profiling in bovine PMNL. 
Gene Name Symbol Function 
Interleukin 10 IL10 
Inhibits the synthesis of a number of cytokines, 
including IFN-gamma, IL-2, IL-3, TNF and GM-CSF 
produced by activated macrophages and by helper T-
cells. 
Interleukin 1 B 
 
IL1B 
Produced by activated macrophages, IL-1 stimulates 
thymocyte proliferation by inducing IL-2 release, B-
cell maturation and proliferation, and fibroblast 
growth factor activity. Potent pro-inflammatory 
cytokine.  
Interleukin 1 Receptor 





This gene encodes the interleukin-1 receptor-
associated kinase 1, one of two putative 
serine/threonine kinases that become associated with 
the interleukin-1 receptor (IL1R) upon stimulation. 
This gene is partially responsible for IL1-induced 
upregulation of the transcription factor NF-kappa B. 
Involved in Toll-like receptor (TLR) and IL-1R 
signaling pathways. Is rapidly recruited by MYD88 to 
the receptor-signaling complex upon TLR activation.  
Nuclear Factor Of Kappa 
Light Polypeptide Gene 





NF-kappa-B is a pleiotropic transcription factor 
present in almost all cell types and is the endpoint of a 
series of signal transduction events that are initiated by 
a vast array of stimuli related to many biological 
processes such as inflammation, immunity, 





Mediates the adherence of lymphocytes to endothelial 
cells of high endothelial venules in peripheral lymph 
nodes. Promotes initial tethering and rolling of 
leukocytes in endothelia. 
Toll-like receptor 2 
 
TLR2 
The protein encoded by this gene is a member of the 
Toll-like receptor (TLR) family which plays a 
fundamental role in pathogen recognition and 
activation of innate immunity. 





The protein encoded by this gene is a member of the 
Toll-like receptor (TLR) family which plays a 
fundamental role in pathogen recognition and 
activation of innate immunity. This receptor has been 
implicated in signal transduction events induced by 
LPS found in most gram-negative bacteria. Mutations 
in this gene have been associated with differences in 
LPS responsiveness 





Secreted by macrophages and can induce cell death of 
certain tumor cell lines. It is potent pyrogen causing 
fever by direct action or by stimulation of interleukin-
1 secretion and is implicated in the induction of 
cachexia, under certain conditions it can stimulate cell 
proliferation and induce cell differentiation. 
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Table 3.3 - Effects of supplementing cows with a control diet (CON) or control diet plus 
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) in blood biomarkers related to liver function and 
inflammation in peripartal dairy cows until 50DIM. 
Parameter 
Treatment   P-value 
CON YC SEM1 Diet Time D × T3 
Liver function 
   Total bilirubin, µmol/L2     1.88    1.98 0.28  0.81 < 0.01 0.70 
   GOT, U/L 93.3 94.6 3.99  0.81 < 0.01 0.72 
   GGT, U/L2 18.3 20.3 0.04  0.03 < 0.01 0.07 
   Cholesterol, mmol/L     3.72     3.53 0.11  0.25 < 0.01 0.96 
   Paraoxonase, U/mL 102.5 95.0 3.4  0.12 < 0.01 0.21 
Inflammation 
   Albumin, g/L 35.6 34.4 0.40  0.06 < 0.01 0.54 
   Ceruloplasmin, µmol/L     2.44     2.48 0.06  0.69 0.03 0.15 
   Haptoglobin, g/L2     0.28     0.36 0.15  0.12 0.09 0.59 
   IL-1β, pg/mL2 32.3 31.2 0.21  0.86 < 0.01 0.17 
1Largest standard error of the mean is shown. 
2Data were log-transformed before statistics. The standard errors of the means associated with log-transformed data are 
in log scale. 

















Table 3.4 - Effects of supplementing cows with a control diet (CON) or control diet plus 
a yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) in PMNL mRNA gene expression in peripartal dairy cows 
until 50DIM. 
Gene1 
Treatment   P-value 
CON YC SEM2 Diet Time D × T3 
Inflammation  
   TNFA 1.41 2.34 1.22  0.11 < 0.01 0.16 
   NFKB1 0.99 1.17 0.23  0.04 0.33 0.42 
   IL1B 3.24 2.32 1.69  0.32 0.28 0.62 
   IL10 1.15 2.19 1.13  0.07 < 0.01 0.17 
Cell receptors and signaling 
   TLR2 1.14 1.40 0.48  0.14 0.05 0.44 
   TLR4 0.94 1.11 0.15  0.33 0.82 0.45 
   SELL 0.93 1.22 0.29  0.11 0.80 0.53 
   IRAK1 1.07 1.20 0.25  0.36 0.24 0.73 
1Fold change data were log-transformed before statistics 
2Largest standard error of the mean is shown. 





Figure 3.1 - Effects of control diet (CON) or control diet plus a yeast culture supplement 
(YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro Animal Health, Teaneck, 
NJ) on blood GGT (A), Paraoxonase (B), Albumin (C) and Haptoglobin (D) in peripartal 
dairy cows until 50DIM. Values are means and the standard errors are represented by 
vertical bars. The P-values for main effect of diet (D) and time (T) and D × T are shown. 
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Figure 3.2 - Expression of genes associated to inflammation (A) and cell receptor and 
signaling (B) in PMNL in  dairy cows fed with control diet (CON) or control diet plus a 
yeast culture supplement (YC; Cellerate Yeast Solutions®, Culture Classic HD; Phibro 
Animal Health, Teaneck, NJ) in peripartal dairy cows until 50DIM. Data are from -30d 
(prepartum), 5d, 15d and 30d (postpartum). The P-values for main effect of diet (D) and 















Days relative to parturition  


























Diet, P = 0.11
Time, P = 0.80
Diet x Time, P = 0.53
Days relative to parturition  





















Diet, P = 0.07
Time, P < 0.01
Diet x Time, P = 0.17
CON
YC






Abdelmegeid, M. K., A. A. Elolimy, Z. Zhou, V. Lopreiato, J. C. McCann, and J. J. Loor. 
2018. Rumen-protected methionine during the peripartal period in dairy cows and 
its effects on abundance of major species of ruminal bacteria. J Anim Sci 
Biotechnol. 9:17. 
Adeyemi, J. A., D. L. Harmon, D. M. P. Compart, and I. M. Ogunade. 2019. Effects of a 
blend of Saccharomyces cerevisiae-based direct-fed microbial and fermentation 
products in the diet of newly weaned beef steers: growth performance, whole-
blood immune gene expression, serum biochemistry, and plasma metabolome1. J 
Anim Sci. 97:4657-4667. 
Al Ibrahim, R. M., A. K. Kelly, L. O'Grady, V. P. Gath, C. McCarney, and F. J. 
Mulligan. 2010. The effect of body condition score at calving and 
supplementation with Saccharomyces cerevisiae on milk production, metabolic 
status, and rumen fermentation of dairy cows in early lactation. J Dairy Sci. 
93:5318-5328. 
Alugongo, G. M., J. Xiao, Z. Wu, S. Li, Y. Wang, and Z. Cao. 2017. Review: Utilization 
of yeast of Saccharomyces cerevisiae origin in artificially raised calves. J Anim 
Sci Biotechnol. 8:34. 
AlZahal, O., L. Dionissopoulos, A. H. Laarman, N. Walker, and B. W. McBride. 2014. 
Active dry Saccharomyces cerevisiae can alleviate the effect of subacute ruminal 
acidosis in lactating dairy cows. J Dairy Sci. 97:7751-7763. 
Andries, J. I., F. X. Buysse, D. L. Brabander de, and B. G. Cottyn. 1987. Isoacids in 
Ruminant Nutrition: Their Role in Ruminal and Intermediary Metabolism and 
Possible Influences on Performances - A Review Animal Feed Science and 
Technology. 18:169-180. 
Aung, M., H. Ohtsuka, and K. Izumi. 2019. Effect of yeast cell wall supplementation on 
production performances and blood biochemical indices of dairy cows in different 
lactation periods. Vet World. 12:796-801. 
Aung, M., H. Ohtsuka, and K. Izumi. 2020. Short communication: Effect of yeast cell 
wall supplementation on peripheral leukocyte populations and mRNA expression 
of cytokines in lactating dairy cows. J Dairy Sci. 103:5634-5640. 
Bach, A., I. Guasch, G. Elcoso, F. Chaucheyras-Durand, M. Castex, F. Fabregas, E. 
Garcia-Fruitos, and A. Aris. 2018. Changes in gene expression in the rumen and 
colon epithelia during the dry period through lactation of dairy cows and effects 
of live yeast supplementation. J Dairy Sci. 101:2631-2640. 
Bach, A., A. Lopez-Garcia, O. Gonzalez-Recio, G. Elcoso, F. Fabregas, F. Chaucheyras-
Durand, and M. Castex. 2019. Changes in the rumen and colon microbiota and 
effects of live yeast dietary supplementation during the transition from the dry 
period to lactation of dairy cows. J Dairy Sci. 102:6180-6198. 
Ballou, M. A. 2011. Inflammation: Role in the etiology and pathophysiology of clinical 
mastitis in dairy cows. J. Anim. Sci. 90:1466-1478. 
Bannerman, D. D., M. Rinaldi, B. T. Vinyard, J. Laihia, and L. Leino. 2009. Effects of 
intramammary infusion of cis–urocanic acid on mastitis-associated inflammation 
and tissue injury in dairy cows. Am. J. Vet. Res. 70:373–382. 
94 
 
Bassel, L. L. and J. L. Caswell. 2018. Bovine neutrophils in health and disease. Cell 
Tissue Res. 371:617-637. 
Batistel, F., J. S. Osorio, A. Ferrari, E. Trevisi, M. T. Socha, and J. J. Loor. 2016. 
Immunometabolic Status during the Peripartum Period Is Enhanced with 
Supplemental Zn, Mn, and Cu from Amino Acid Complexes and Co from Co 
Glucoheptonate. PLoS One. 11:e0155804. 
Batistel, F., J. S. Osorio, M. R. Tariq, C. Li, J. Caputo, M. T. Socha, and J. J. Loor. 2017. 
Peripheral leukocyte and endometrium molecular biomarkers of inflammation and 
oxidative stress are altered in peripartal dairy cows supplemented with Zn, Mn, 
and Cu from amino acid complexes and Co from Co glucoheptonate. J Anim Sci 
Biotechnol. 8:33. 
Bazzoni, F., N. Tamassia, M. Rossato, and M. A. Cassatella. 2010. Understanding the 
molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory 
response: lessons from neutrophils. Eur J Immunol. 40:2360-2368. 
Bernabucci, U., L. Basiricò, D. Pirazzi, F. Rueca, N. Lacetera, E. Lepri, and A. Nardone. 
2009. Liver apolipoprotein B100 expression and secretion are down-regulated 
early postpartum in dairy cows. Livestock Science. 125:169-176. 
Bernabucci, U., B. Ronchi, L. Basiricò, D. Pirazzi, F. Rueca, N. Lacetera, and A. 
Nardone. 2004. Abundance of mRNA of Apolipoprotein B100, Apolipoprotein E, 
and Microsomal Triglyceride Transfer Protein in Liver from Periparturient Dairy 
Cows. J. Dairy Science. 87:2881–2888. 
Bertoni, G., A. Minuti, and E. Trevisi. 2015. Immune system, inflammation and nutrition 
in dairy cattle. Animal Production Science. 55. 
Bertoni, G. and E. Trevisi. 2013. Use of the liver activity index and other metabolic 
variables in the assessment of metabolic health in dairy herds. Vet Clin North Am 
Food Anim Pract. 29:413-431. 
Bertoni, G., E. Trevisi, X. Han, and M. Bionaz. 2008. Effects of inflammatory conditions 
on liver activity in puerperium period and consequences for performance in dairy 
cows. J Dairy Sci. 91:3300-3310. 
Bionaz, M. and J. J. Loor. 2007. Identification of reference genes for quantitative real-
time PCR in the bovine mammary gland during the lactation cycle. Physiol 
Genomics. 29:312-319. 
Bionaz, M., E. Trevisi, L. Calamari, F. Librandi, A. Ferrari, and G. Bertoni. 2007. Plasma 
paraoxonase, health, inflammatory conditions, and liver function in transition 
dairy cows. J Dairy Sci. 90:1740-1750. 
Bobe, G., J. W. Young, and D. C. Beitz. 2004. Invited Review: Pathology, Etiology, 
Prevention, and Treatment of Fatty Liver in Dairy Cows. J Dairy Sci. 87:3105–
3124. 
Bradford, B. J. and M. S. Allen. 2004. Milk Fat Responses to a Change in Diet 
Fermentability Vary by Production Level in Dairy Cattle. Journal of Dairy 
Science. 87:3800-3807. 
Bradford, B. J., K. Yuan, J. K. Farney, L. K. Mamedova, and A. J. Carpenter. 2015. 
Invited review: Inflammation during the transition to lactation: New adventures 
with an old flame. J Dairy Sci. 98:6631-6650. 




Callaway, T. R. and S. A. Martin. 1997. Effects of a Saccharomyces cerevisiae Culture 
on Ruminal Bacteria that Utilize Lactate and Digest Cellulose. J Dairy Sci. 
80:2035–2044. 
Ceciliani, F., J. J. Ceron, P. D. Eckersall, and H. Sauerwein. 2012. Acute phase proteins 
in ruminants. J Proteomics. 75:4207-4231. 
Champe, P. C., R. A. Harvey, and D. R. Ferrier. 2005. Biochemistry. Lippincott Williams 
& Wilkins. 
Chaney, A. L. and E. P. Marbach. 1962. Modified reagents for determination of urea and 
ammonia. Clin. Chem. 8:130-132. 
Chaucheyras-Durand, F. and G. Fonty. 2009. Influence of a Probiotic Yeast ( 
Saccharomyces cerevisiae CNCM I-1077) on Microbial Colonization and 
Fermentations in the Rumen of Newborn Lambs. Microbial Ecology in Health 
and Disease. 14:30-36. 
Chaucheyras-Durand, F., N. D. Walker, and A. Bach. 2008. Effects of active dry yeasts 
on the rumen microbial ecosystem: Past, present and future. Animal Feed Science 
and Technology. 145:5-26. 
Contreras, G. A. and L. M. Sordillo. 2011. Lipid mobilization and inflammatory 
responses during the transition period of dairy cows. Comp Immunol Microbiol 
Infect Dis. 34:281-289. 
Contreras, G. A., C. Strieder-Barboza, and W. Raphael. 2017 Adipose tissue lipolysis and 
remodeling during the transition period of dairy cows. Journal of Animal Science 
and Biotechnology. 8. 
Daha, M. R. 2011. Grand challenges in molecular innate immunity. Front Immunol. 2:16. 
Dann, H. M., J. K. Drackley, G. C. McCoy, M. F. Hutjens, and J. E. Garrett. 2000. 
Effects of Yeast Culture (Saccharomyces cerevisiae) on Prepartum Intake and 
Postpartum Intake and Milk Production of Jersey Cows. 
Dawson, K. A., K. E. Newman, and J. A. Boling. 1990. Effects of microbial supplements 
containing live yeast and lactobacilli on roughage-fed ruminal microbial 
activities. J. Anim. Sci. 68:3392-3398. 
Denman, S. E. and C. S. McSweeney. 2006. Development of a real-time PCR assay for 
monitoring anaerobic fungal and cellulolytic bacterial populations within the 
rumen. FEMS Microbiol Ecol. 58:572-582. 
Desnoyers, M., S. Giger-Reverdin, G. Bertin, C. Duvaux-Ponter, and D. Sauvant. 2009. 
Meta-analysis of the influence of Saccharomyces cerevisiae supplementation on 
ruminal parameters and milk production of ruminants. J Dairy Sci. 92:1620-1632. 
Dias, A. L. G., J. A. Freitas, B. Micai, R. A. Azevedo, L. F. Greco, and J. E. P. Santos. 
2018. Effect of supplemental yeast culture and dietary starch content on rumen 
fermentation and digestion in dairy cows. J Dairy Sci. 101:201-221. 
Drackley, J. K. 1999. Biology of Dairy Cows During the Transition Period: the Final 
Frontier? J Dairy Sci. 82:2259–2273. 
Drackley, J. K., S. S. Donkin, and C. K. Reynolds. 2006. Major Advances in 
Fundamental Dairy Cattle Nutrition. J Dairy Sci. 89  
Duffield, T. 2000. Subclinical Ketosis in Lactating Dairy Cattle. Veterinary Clinics of 
North America: Food Animal Practice. 16:231-253. 
Emery, R. S., J. S. Liesman, and T. H. Herdt. 1992. Metabolism of Long Chain Fatty 
Acids by Ruminant Liver. The Journal of Nutrition. 122:832-837. 
96 
 
Faccio-Demarco, C., T. Mumbach, V. Oliveira-de-Freitas, E. S.-R. R. Fraga, F. 
Medeiros-Goncalves, M. Nunes-Correa, F. A. Burkert-Del Pino, H. Mendonca-
Nunes-Ribeiro Filho, and C. Cassal-Brauner. 2019. Effect of yeast products 
supplementation during transition period on metabolic profile and milk 
production in dairy cows. Trop Anim Health Prod. 51:2193-2201. 
Fonty, G. and F. Chaucheyras-Durand. 2006. Effects and modes of action of live yeasts 
in the rumen. Biologia. 61. 
Garcia Diaz, T., A. Ferriani Branco, F. A. Jacovaci, C. Cabreira Jobim, J. L. Pratti 
Daniel, A. V. Iank Bueno, and M. Goncalves Ribeiro. 2018. Use of live yeast and 
mannan-oligosaccharides in grain-based diets for cattle: Ruminal parameters, 
nutrient digestibility, and inflammatory response. PLoS One. 13:e0207127. 
Gauldie, J., C. Richards, D. Harnish, P. Lansdorp, and H. Baumann. 1987. Interferon 
beta-2/B-cell stimulatory factor type 2 shares identity with monocyte-derived 
hepatocyte-stimulating factor and regulates the major acute phase protein 
response in liver cells. Proc Natl Acad Sci USA. 84:7251-7255,. 
Ghazanfar, S., N. Khalid, I. Ahmed, and M. Imran. 2017. Probiotic Yeast: Mode of 
Action and Its Effects on Ruminant Nutrition. in Yeast - Industrial Applications. 
Goff, J. P. and R. L. Horst. 1997. Physiological Changes at Parturition and Their 
Relationship to Metabolic Disorders. J. Dairy Science. 80. 
Goodridge, H. S., A. J. Wolf, and D. M. Underhill. 2009. Beta-glucan recognition by the 
innate immune system. Immunol Rev. 230:38-50. 
Gordon, J. L., S. J. Leblanc, and T. F. Duffield. 2013. Ketosis treatment in lactating dairy 
cattle. Vet Clin North Am Food Anim Pract. 29:433-445. 
Grazziotin, R. C. B., J. Halfen, F. Rosa, E. Schmitt, J. L. Anderson, V. Ballard, and J. S. 
Osorio. 2020. Altered rumen fermentation patterns in lactating dairy cows 
supplemented with phytochemicals improve milk production and efficiency. J 
Dairy Sci. 103:301-312. 
Grum, D. E., J. K. Drackley, R. S. Younker, D. W. LaCount, and J. J. Veenhuizen. 1996. 
Nutrition During the Dry Period and Hepatic Lipid Metabolism of Periparturient 
Dairy Cows. J Dairy Sci. 79:1850-1864. 
Grummer, R. R. 1993. Etiology of Lipid-Related Metabolic Disorders In Perlparturient 
Dairy Cows. J Dairy Sci 76:3882-3896. 
Grummer, R. R. 1995. Impact of changes in organic nutrient metabolism on feeding the 
transition dairy cow. J Anim Sci. 73:2820-2833. 
Grummer, R. R. 2008. Nutritional and management strategies for the prevention of fatty 
liver in dairy cattle. Vet J. 176:10-20. 
Grummer, R. R., D. G. Mashek, and A. Hayirli. 2004. Dry matter intake and energy 
balance in the transition period. Vet Clin North Am Food Anim Pract. 20:447-
470. 
Harrison, G. A., R. W. Hemken, K. A. Dawson, H. R. J., and K. B. Barker. 1988. 
Influence of Addition of Yeast Culture Supplement to Diets of Lactating Cows on 
Ruminal Fermentation and Microbial Populations. J Dairy Sci. 71:2967-2975. 
Henderson, G., F. Cox, S. Kittelmann, V. H. Miri, M. Zethof, S. J. Noel, G. C. Waghorn, 
and P. H. Janssen. 2013. Effect of DNA extraction methods and sampling 
techniques on the apparent structure of cow and sheep rumen microbial 
communities. PLoS One. 8:e74787. 
97 
 
Hidalgo, A., E. R. Chilvers, C. Summers, and L. Koenderman. 2019. The Neutrophil Life 
Cycle. Trends Immunol. 40:584-597. 
Hutjens, M. F. 2010. Benchmarking Your Feed Efficiency, Feed Costs, and Income over 
Feed Cost. WCDS Advances in Dairy Technology. 22:3-10. 
Ingvartsen, K. L. 2006. Feeding- and management-related diseases in the transition cow. 
Animal Feed Science and Technology. 126:175-213. 
Ingvartsen, K. L. and J. B. Andersen. 2000. Integration of Metabolism and Intake 
Regulation: A Review Focusing on Periparturient Animals. J Dairy Sci. 83:1573–
1597. 
Ingvartsen, K. L. and K. Moyes. 2013. Nutrition, immune function and health of dairy 
cattle. Animal. 7 Suppl 1:112-122. 
Jacometo, C. B., Z. Zhou, D. Luchini, E. Trevisi, M. N. Correa, and J. J. Loor. 2016. 
Maternal rumen-protected methionine supplementation and its effect on blood and 
liver biomarkers of energy metabolism, inflammation, and oxidative stress in 
neonatal Holstein calves. J Dairy Sci. 99:6753-6763. 
Janovick, N. A., Y. R. Boisclair, and J. K. Drackley. 2011. Prepartum dietary energy 
intake affects metabolism and health during the periparturient period in 
primiparous and multiparous Holstein cows. J Dairy Sci. 94:1385-1400. 
Jensen, G. S., K. M. Patterson, and I. Yoon. 2008. Yeast culture has anti-inflammatory 
effects and specifically activates NK cells. Comp Immunol Microbiol Infect Dis. 
31:487-500. 
Jiang, Y., I. M. Ogunade, K. G. Arriola, M. Qi, D. Vyas, C. R. Staples, and A. T. 
Adesogan. 2017a. Effects of the dose and viability of Saccharomyces cerevisiae. 
2. Ruminal fermentation, performance of lactating dairy cows, and correlations 
between ruminal bacteria abundance and performance measures. J Dairy Sci. 
100:8102-8118. 
Jiang, Y., I. M. Ogunade, S. Qi, T. J. Hackmann, C. R. Staples, and A. T. Adesogan. 
2017b. Effects of the dose and viability of Saccharomyces cerevisiae. 1. Diversity 
of ruminal microbes as analyzed by Illumina MiSeq sequencing and quantitative 
PCR. J Dairy Sci. 100:325-342. 
Jiao, P., C. Wei, Y. Sun, X. Xie, Y. Zhang, S. Wang, G. Hu, O. AlZahal, and W. Yang. 
2019. Screening of live yeast and yeast derivatives for their impact of strain and 
dose on in vitro ruminal fermentation and microbial profiles with varying media 
pH levels in high-forage beef cattle diet. J Sci Food Agric. 99:6751-6760. 
Jin, X., M. Zhang, G. F. Cao, and Y. F. Yang. 2019. Saccharomyces cerevisiae mannan 
induces sheep beta-defensin-1 expression via Dectin-2-Syk-p38 pathways in 
ovine ruminal epithelial cells. Vet Res. 50:8. 
Jouany, J. P. 2006. Optimizing rumen functions in the close-up transition period and 
early lactation to drive dry matter intake and energy balance in cows. Anim 
Reprod Sci. 96:250-264. 
Khafipour, E., S. Li, J. C. Plaizier, and D. O. Krause. 2009. Rumen microbiome 
composition determined using two nutritional models of subacute ruminal 
acidosis. Appl Environ Microbiol. 75:7115-7124. 
Kim, H. S., J. T. Hong, Y. Kim, and S. B. Han. 2011. Stimulatory Effect of beta-glucans 
on Immune Cells. Immune Netw. 11:191-195. 
98 
 
Klieve, A. V., D. Hennessy, D. Ouwerkerk, R. J. Forster, R. I. Mackie, and G. T. 
Attwood. 2003. Establishing populations of Megasphaera elsdenii YE 34 and 
Butyrivibrio fibrisolvens YE 44 in the rumen of cattle fed high grain diets. J Appl 
Microbiol. 95:621-630. 
Knoblock, C. E., W. Shi, I. Yoon, and M. Oba. 2019. Effects of supplementing a 
Saccharomyces cerevisiae fermentation product during the periparturient period 
on the immune response of dairy cows fed fresh diets differing in starch content. J 
Dairy Sci. 102:6199-6209. 
Koike, S. and Y. Kobayashi. 2001. Development and use of competitive PCR assays for 
the rumen cellulolytic bacteria: Fibrobacter succinogenes, Ruminococcus albus 
and Ruminococcus Flavefaciens. FEMS Microbiology Letters. 361-366. 
Korolenko, T. A., N. P. Bgatova, and V. Vetvicka. 2019. Glucan and Mannan-Two Peas 
in a Pod. Int J Mol Sci. 20. 
Kumprechtova, D., J. Illek, C. Julien, P. Homolka, F. Jancik, and E. Auclair. 2019. Effect 
of live yeast (Saccharomyces cerevisiae) supplementation on rumen fermentation 
and metabolic profile of dairy cows in early lactation. J Anim Physiol Anim Nutr 
(Berl). 103:447-455. 
Kvidera, S. K., E. A. Horst, M. Abuajamieh, E. J. Mayorga, M. V. Fernandez, and L. H. 
Baumgard. 2017. Glucose requirements of an activated immune system in 
lactating Holstein cows. J Dairy Sci. 100:2360-2374. 
Lacetera, N., D. Scalia, U. Bernabucci, B. Ronchi, D. Pirazzi, and A. Nardone. 2005. 
Lymphocyte functions in overconditioned cows around parturition. J Dairy Sci. 
88:2010–2016. 
Lascano, G. J. and A. J. Heinrichs. 2009. Rumen fermentation pattern of dairy heifers fed 
restricted amounts of low, medium, and high concentrate diets without and with 
yeast culture. Livestock Science. 124:48-57. 
LeBlanc, S. J. 2020. Review: Relationships between metabolism and neutrophil function 
in dairy cows in the peripartum period. Animal. 14:s44-s54. 
Lee, J. Y. and D. H. Hwang. 2006. The Modulation of Inflammatory Gene Expression by 
Lipids: Mediation through Toll-like Receptors. Mol. Cells. 21:174-185. 
Lima, F. S., G. Oikonomou, S. F. Lima, M. L. Bicalho, E. K. Ganda, J. C. Filho, G. 
Lorenzo, P. Trojacanec, and R. C. Bicalhoa. 2015. Prepartum and postpartum 
rumen fluid microbiomes: characterization and correlation with production traits 
in dairy cows. Appl Environ Microbiol. 81:1327-1337. 
Liu, Q., C. Wang, Y. X. Huang, K. H. Dong, W. Z. Yang, S. L. Zhang, and H. Wang. 
2009. Effects of isovalerate on ruminal fermentation, urinary excretion of purine 
derivatives and digestibility in steers. J Anim Physiol Anim Nutr (Berl). 93:716-
725. 
Longuski, R. A., Y. Ying, and M. S. Allen. 2009. Yeast culture supplementation 
prevented milk fat depression by a short-term dietary challenge with fermentable 
starch. J Dairy Sci. 92:160-167. 
Lopreiato, V., M. Mezzetti, L. Cattaneo, G. Ferronato, A. Minuti, and E. Trevisi. 2020. 
Role of nutraceuticals during the transition period of dairy cows: a review. J Anim 
Sci Biotechnol. 11:96. 
McFadden, J. W. 2020. Review: Lipid biology in the periparturient dairy cow: 
contemporary perspectives. Animal. 14:s165-s175. 
99 
 
Meller, R. A., B. A. Wenner, J. Ashworth, A. M. Gehman, J. Lakritz, and J. L. Firkins. 
2019. Potential roles of nitrate and live yeast culture in suppressing methane 
emission and influencing ruminal fermentation, digestibility, and milk production 
in lactating Jersey cows. J Dairy Sci. 102:6144-6156. 
Mezzetti, M., A. Minuti, F. Piccioli-Cappelli, M. Amadori, M. Bionaz, and E. Trevisi. 
2019. The role of altered immune function during the dry period in promoting the 
development of subclinical ketosis in early lactation. J Dairy Sci. 102:9241-9258. 
Minuti, A., A. Palladino, M. J. Khan, S. Alqarni, A. Agrawal, F. Piccioli-Capelli, F. 
Hidalgo, F. C. Cardoso, E. Trevisi, and J. J. Loor. 2015. Abundance of ruminal 
bacteria, epithelial gene expression, and systemic biomarkers of metabolism and 
inflammation are altered during the peripartal period in dairy cows. J Dairy Sci. 
98:8940-8951. 
Moore, K. W., R. d. W. Malefyt, R. L. Coofman, and A. O’Garra. 2001. Interleukin-10 
and the Interleukin-10 receptor. Annu. Rev. Immunol. . 19:683–765. 
Moyes, K. M., J. K. Drackley, D. E. Morin, and J. J. Loor. 2010. Greater expression of 
TLR2, TLR4, and IL6 due to negative energy balance is associated with lower 
expression of HLA-DRA and HLA-A in bovine blood neutrophils after 
intramammary mastitis challenge with Streptococcus uberis. Funct Integr 
Genomics. 10:53-61. 
Moyes, K. M., D. E. Graugnard, M. J. Khan, M. Mukesh, and J. J. Loor. 2014. Postpartal 
immunometabolic gene network expression and function in blood neutrophils are 
altered in response to prepartal energy intake and postpartal intramammary 
inflammatory challenge. J Dairy Sci. 97:2165-2177. 
Mullins, C. R., L. K. Mamedova, A. J. Carpenter, Y. Ying, M. S. Allen, I. Yoon, and B. 
J. Bradford. 2013. Analysis of rumen microbial populations in lactating dairy 
cattle fed diets varying in carbohydrate profiles and Saccharomyces cerevisiae 
fermentation product. J Dairy Sci. 96:5872-5881. 
Newbold, C. J., R. J. Wallace, and F. M. McIntosh. 1996. Mode of action of the yeast 
Sacchavomyces cerevisiae as a feed additive for ruminants. British Joiiriinl of 
Nutrition. 76:249-261. 
Nocek, J. E., M. G. Holt, and J. Oppy. 2011. Effects of supplementation with yeast 
culture and enzymatically hydrolyzed yeast on performance of early lactation 
dairy cattle. J Dairy Sci. 94:4046-4056. 
Nocek, J. E., W. P. Kautz, J. A. Z. Leedle, and E. Block. 2003. Direct-Fed Microbial 
Supplementation on the Performance of Dairy Cattle During the Transition 
Period. J. Dairy Science. 86:331–335. 
NRC. 2001. Nutrient Requirements of Dairy Cattle. Vol. 7th. Natl. Acad. Press, 
Washington, DC. 
Oetzel, G. R. 2004. Monitoring and testing dairy herds for metabolic disease. Vet Clin 
North Am Food Anim Pract. 20:651-674. 
Ogunade, I. M., J. Lay, K. Andries, C. J. McManus, and F. Bebe. 2019. Effects of live 
yeast on differential genetic and functional attributes of rumen microbiota in beef 
cattle. J Anim Sci Biotechnol. 10:68. 
Olagaray, K. E., S. E. Sivinski, B. A. Saylor, L. K. Mamedova, J. A. Sauls-Hiesterman, I. 
Yoon, and B. J. Bradford. 2019. Effect of Saccharomyces cerevisiae fermentation 
100 
 
product on feed intake parameters, lactation performance, and metabolism of 
transition dairy cattle. J Dairy Sci. 102:8092-8107. 
Osorio, J. S., P. Ji, J. K. Drackley, D. Luchini, and J. J. Loor. 2013a. Supplemental 
Smartamine M or MetaSmart during the transition period benefits postpartal cow 
performance and blood neutrophil function. J Dairy Sci. 96:6248-6263. 
Osorio, J. S., J. Lohakare, and M. Bionaz. 2016. Biosynthesis of milk fat, protein, and 
lactose: roles of transcriptional and posttranscriptional regulation. Physiol 
Genomics. 48:231-256. 
Osorio, J. S., E. Trevisi, M. A. Ballou, G. Bertoni, J. K. Drackley, and J. J. Loor. 2013b. 
Effect of the level of maternal energy intake prepartum on immunometabolic 
markers, polymorphonuclear leukocyte function, and neutrophil gene network 
expression in neonatal Holstein heifer calves. J Dairy Sci. 96:3573-3587. 
Overton, T. R. and M. R. Waldron. 2004. Nutritional Management of Transition Dairy 
Cows: Strategies to Optimize Metabolic Health. J Dairy Sci. 87:E105–E119. 
Paape, M. J., D. D. Bannerman, X. Zhao, and J. W. Lee. 2003. The bovine neutrophil: 
Structure and function in blood and milk. Vet Res. 34:597-627. 
Perdomo, M. C., R. S. Marsola, M. G. Favoreto, A. Adesogan, C. R. Staples, and J. E. P. 
Santos. 2020. Effects of feeding live yeast at 2 dosages on performance and 
feeding behavior of dairy cows under heat stress. J Dairy Sci. 103:325-339. 
Pinloche, E., N. McEwan, J. P. Marden, C. Bayourthe, E. Auclair, and C. J. Newbold. 
2013. The effects of a probiotic yeast on the bacterial diversity and population 
structure in the rumen of cattle. PLoS One. 8:e67824. 
Piva, G., S. Belladonna, G. Fusconi, and F. Sicbaldi. 1993. Effects of Yeast on Dairy 
Cow Performance, Rumlnal Fermentation, Blood Components, and Milk 
Manufacturing Propertles. J. Dairy Science. 76:2717-2722. 
Poppy, G. D., A. R. Rabiee, I. J. Lean, W. K. Sanchez, K. L. Dorton, and P. S. Morley. 
2012. A meta-analysis of the effects of feeding yeast culture produced by 
anaerobic fermentation of Saccharomyces cerevisiae on milk production of 
lactating dairy cows. J Dairy Sci. 95:6027-6041. 
Proust, L., E. Haudebourg, A. Sourabie, M. Pedersen, I. Besancon, V. Monnet, and V. 
Juillard. 2020. Multi-omics approach reveals how yeast extract peptides shape 
Streptococcus thermophilus metabolism. Appl Environ Microbiol. 
Puniya, A. K., R. Singh, and D. N. Kamra. 2015. Rumen microbiology: from evolution to 
revolution. 
Raffler, N. A., J. Rivera-Nieves, and K. Ley. 2005. L-selectin in inflammation, infection 
and immunity. Drug Discovery Today: Therapeutic Strategies. 2:213-220. 
Robinson, P. H. and L. J. Erasmus. 2009. Effects of analyzable diet components on 
responses of lactating dairy cows to Saccharomyces cerevisiae based yeast 
products: A systematic review of the literature. Animal Feed Science and 
Technology. 149:185-198. 
Robinson, P. H. and J. E. Garrett. 1999. Effect of Yeast Culture (Saccharomyces 
cerevisiae) on Adaptation of Cows to Postpartum Diets and on Lactational 
Performance. J. Anim. Sci. 77:988–999. 
Roche, J. R., A. W. Bell, T. R. Overton, and J. J. Loor. 2013. Nutritional management of 
the transition cow in the 21st century – a paradigm shift in thinking. Animal 
Production Science. 53. 
101 
 
Rodriguez-Jimenez, S., K. J. Haerr, E. Trevisi, J. J. Loor, F. C. Cardoso, and J. S. Osorio. 
2018. Prepartal standing behavior as a parameter for early detection of postpartal 
subclinical ketosis associated with inflammation and liver function biomarkers in 
peripartal dairy cows. J Dairy Sci. 101:8224-8235. 
Russell, J. B. 2002. Rumen microbiology and its role in ruminant nutrition. Department 
of Microbiology, Cornell University. 
Shabat, S. K. B., G. Sasson, A. Doron-Faigenboim, T. Durman, S. Yaacoby, M. E. Berg 
Miller, B. A. White, N. Shterzer, and I. Mizrahi. 2016. Specific microbiome-
dependent mechanisms underlie the energy harvest efficiency of ruminants. The 
ISME Journal. 10:2958-2972. 
Shi, W., C. E. Knoblock, K. V. Murphy, T. C. Bruinje, I. Yoon, D. J. Ambrose, and M. 
Oba. 2019. Effects of supplementing a Saccharomyces cerevisiae fermentation 
product during the periparturient period on performance of dairy cows fed fresh 
diets differing in starch content. J Dairy Sci. 102:3082-3096. 
Sordillo, L. M. 2016. Nutritional strategies to optimize dairy cattle immunity. J Dairy Sci. 
99:4967-4982. 
Sordillo, L. M. and S. L. Aitken. 2009. Impact of oxidative stress on the health and 
immune function of dairy cattle. Vet Immunol Immunopathol. 128:104-109. 
Sordillo, L. M., G. A. Contreras, and S. L. Aitken. 2009. Metabolic factors affecting the 
inflammatory response of periparturient dairy cows. Anim Health Res Rev. 10:53-
63. 
Sordillo, L. M. and V. Mavangira. 2014. The nexus between nutrient metabolism, 
oxidative stress and inflammation in transition cows. Animal Production Science. 
54. 
Sordillo, L. M., K. Shafer-Weaver, and D. DeRosa. 1997. Immunobiology of the 
Mammary Gland. J. Dairy Science. 80:1851–1865. 
Sordillo, L. M. and K. L. Streicher. 2002. Mammary Gland Immunity and Mastitis 
Susceptibility. Journal of Mammary Gland Biology and Neoplasia. 7. 
Stefenoni, H., J. H. Harrison, A. Adams-Progar, and E. Block. 2020. Effect of 
enzymatically hydrolyzed yeast on health and performance of transition dairy 
cattle. J Dairy Sci. 103:1541-1552. 
Stevenson, D. M. and P. J. Weimer. 2007. Dominance of Prevotella and low abundance 
of classical ruminal bacterial species in the bovine rumen revealed by relative 
quantification real-time PCR. Appl Microbiol Biotechnol. 75:165-174. 
Tajima, K., R. I. Aminov, T. Nagamine, H. Matsui, M. Nakamura, and Y. Benno. 2001. 
Diet-dependent shifts in the bacterial population of the rumen revealed with real-
time PCR. Appl Environ Microbiol. 67:2766-2774. 
Trevisi, E., M. Amadori, I. Archetti, N. Lacetera, and G. Bertoni. 2011. Inflammatory 
Response and Acute Phase Proteins in the Transition Period of High-Yielding 
Dairy Cows. in Acute Phase Proteins as Early Non-Specific Biomarkers of 
Human and Veterinary Diseases. 
Trevisi, E., M. Amadori, S. Cogrossi, E. Razzuoli, and G. Bertoni. 2012. Metabolic stress 
and inflammatory response in high-yielding, periparturient dairy cows. Res Vet 
Sci. 93:695-704. 
Trevisi, E. and A. Minuti. 2018. Assessment of the innate immune response in the 
periparturient cow. Res Vet Sci. 116:47-54. 
102 
 
Trevisi, E., A. Zecconi, G. Bertoni, and R. Piccinini. 2010. Blood and milk immune and 
inflammatory profiles in periparturient dairy cows showing a different liver 
activity index. J Dairy Res. 77:310-317. 
Turk, R., D. Juretic, D. Geres, N. Turk, B. Rekic, V. Simeon-Rudolf, and A. Svetina. 
2004. Serum paraoxonase activity and lipid parameters in the early postpartum 
period of dairy cows. Res Vet Sci. 76:57-61. 
Vailati-Riboni, M., T. Xu, B. Qadir, R. Bucktrout, C. Parys, and J. J. Loor. 2019. In vitro 
methionine supplementation during lipopolysaccharide stimulation modulates 
immunometabolic gene network expression in isolated polymorphonuclear cells 
from lactating Holstein cows. J Dairy Sci. 102:8343-8351. 
Van den Top, A. M., A. Van Tol, H. Jansen, M. J. Geelen, and A. C. Beynen. 2005. Fatty 
liver in dairy cows post partum is associated with decreased concentration of 
plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytes. 
J Dairy Res. 72:129-137. 
Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. 
Speleman. 2002. Accurate normalization of real-time quantitative RT-PCR data 
by geometric averaging of multiple internal control genes. Genome Biol. 
3:RESEARCH0034. 
Walachowski, S., G. Tabouret, and G. Foucras. 2016. Triggering Dectin-1-Pathway 
Alone Is Not Sufficient to Induce Cytokine Production by Murine Macrophages. 
PLoS One. 11:e0148464. 
Waller, P. K., U. Gronlund, and A. Johannisson. 2003. Intramammary Infusion of b1,3-
glucan for Prevention and Treatment of Staphylococcus aureus Mastitis. J. Vet. 
Med. 50:121-127. 
Weedman, S. M., M. H. Rostagno, J. A. Patterson, I. Yoon, G. Fitzner, and S. D. Eicher. 
2011. Yeast culture supplement during nursing and transport affects immunity 
and intestinal microbial ecology of weanling pigs. J Anim Sci. 89:1908-1921. 
Weimer, P. J. and G. N. Moen. 2013. Quantitative analysis of growth and volatile fatty 
acid production by the anaerobic ruminal bacterium Megasphaera elsdenii T81. 
Appl Microbiol Biotechnol. 97:4075-4081. 
Welty, C. M., B. A. Wenner, B. K. Wagner, Y. Roman-Garcia, J. E. Plank, R. A. Meller, 
A. M. Gehman, and J. L. Firkins. 2019. Rumen microbial responses to 
supplemental nitrate. II. Potential interactions with live yeast culture on the 
prokaryotic community and methanogenesis in continuous culture. J Dairy Sci. 
102:2217-2231. 
White, H. 2015. The Role of TCA Cycle Anaplerosis in Ketosis and Fatty Liver in 
Periparturient Dairy Cows. Animals. 5:793-802. 
Willcocks, S., Y. Yamakawa, A. Stalker, T. J. Coffey, T. Goldammer, and D. Werling. 
2006. Identification and gene expression of the bovine C-type lectin Dectin-1. Vet 
Immunol Immunopathol. 113:234-242. 
Won, M. Y., L. B. Oyama, S. J. Courtney, C. J. Creevey, and S. A. Huws. 2020. Can 
rumen bacteria communicate to each other? Microbiome. 8:23. 
Yuan, K., T. Liang, M. B. Muckey, L. G. Mendonca, L. E. Hulbert, C. C. Elrod, and B. J. 
Bradford. 2015a. Yeast product supplementation modulated feeding behavior and 
metabolism in transition dairy cows. J Dairy Sci. 98:532-540. 
103 
 
Yuan, K., L. G. Mendonca, L. E. Hulbert, L. K. Mamedova, M. B. Muckey, Y. Shen, C. 
C. Elrod, and B. J. Bradford. 2015b. Yeast product supplementation modulated 
humoral and mucosal immunity and uterine inflammatory signals in transition 
dairy cows. J Dairy Sci. 98:3236-3246. 
Zanello, G., M. Berri, J. Dupont, P. Y. Sizaret, R. D'Inca, H. Salmon, and F. Meurens. 
2011. Saccharomyces cerevisiae modulates immune gene expressions and inhibits 
ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. 
PLoS One. 6:e18573. 
Zaworski, E. M., C. M. Shriver-Munsch, N. A. Fadden, W. K. Sanchez, I. Yoon, and G. 
Bobe. 2014. Effects of feeding various dosages of Saccharomyces cerevisiae 
fermentation product in transition dairy cows. J Dairy Sci. 97:3081-3098. 
Zeineldin, M., R. Barakat, A. Elolimy, A. Z. M. Salem, M. M. Y. Elghandour, and J. C. 
Monroy. 2018. Synergetic action between the rumen microbiota and bovine 
health. Microb Pathog. 124:106-115. 
Zhang, M., X. Jin, and Y. F. Yang. 2019. beta-Glucan from Saccharomyces cerevisiae 
induces SBD-1 production in ovine ruminal epithelial cells via the Dectin-1-Syk-
NF-kappaB signaling pathway. Cell Signal. 53:304-315. 
Zhou, Z., D. P. Bu, M. Vailati Riboni, M. J. Khan, D. E. Graugnard, J. Luo, F. C. 
Cardoso, and J. J. Loor. 2015. Prepartal dietary energy level affects peripartal 
bovine blood neutrophil metabolic, antioxidant, and inflammatory gene 
expression. J Dairy Sci. 98:5492-5505. 
Zhou, Z., O. Bulgari, M. Vailati-Riboni, E. Trevisi, M. A. Ballou, F. C. Cardoso, D. N. 
Luchini, and J. J. Loor. 2016. Rumen-protected methionine compared with 
rumen-protected choline improves immunometabolic status in dairy cows during 
the peripartal period. J Dairy Sci. 99:8956-8969. 
Zhu, W., Z. Wei, N. Xu, F. Yang, I. Yoon, Y. Chung, J. Liu, and J. Wang. 2017. Effects 
of Saccharomyces cerevisiae fermentation products on performance and rumen 
fermentation and microbiota in dairy cows fed a diet containing low quality 
forage. J Anim Sci Biotechnol. 8:36. 
Zhu, Y., G. Liu, X. Du, Z. Shi, M. Jin, X. Sha, X. Li, Z. Wang, and X. Li. 2019. 
Expression patterns of hepatic genes involved in lipid metabolism in cows with 
subclinical or clinical ketosis. J Dairy Sci. 102:1725-1735. 
Ziegler-Heitbrock, L. 2014. Monocyte subsets in man and other species. Cell Immunol. 
289:135-139. 
 
